<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties manuscript?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-journal-id">9102136</journal-id><journal-id journal-id-type="pubmed-jr-id">1030</journal-id><journal-id journal-id-type="nlm-ta">J Adolesc Health</journal-id><journal-id journal-id-type="iso-abbrev">J Adolesc Health</journal-id><journal-title-group><journal-title>The Journal of adolescent health : official publication of the Society for Adolescent Medicine</journal-title></journal-title-group><issn pub-type="ppub">1054-139X</issn><issn pub-type="epub">1879-1972</issn></journal-meta><article-meta><article-id pub-id-type="pmid">39352358</article-id><article-id pub-id-type="pmc">11870123</article-id><article-id pub-id-type="doi">10.1016/j.jadohealth.2024.07.030</article-id><article-id pub-id-type="manuscript">HHSPA2049072</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Adolescents&#x02019; Adverse Childhood Experiences, Poor Mental
Health, and Substance Use During the COVID-19 Pandemic</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Swedo</surname><given-names>Elizabeth A.</given-names></name><degrees>M.D.</degrees><xref rid="A1" ref-type="aff">a</xref><xref rid="CR1" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name><surname>Anderson</surname><given-names>Kayla N.</given-names></name><degrees>Ph.D.</degrees><xref rid="A1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Okwori</surname><given-names>Glory</given-names></name><degrees>Dr.PH.</degrees><xref rid="A2" ref-type="aff">b</xref></contrib><contrib contrib-type="author"><name><surname>DePadilla</surname><given-names>Lara</given-names></name><degrees>Ph.D.</degrees><xref rid="A3" ref-type="aff">c</xref></contrib><contrib contrib-type="author"><name><surname>Clayton</surname><given-names>Heather B.</given-names></name><degrees>Ph.D.</degrees><xref rid="A1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Villaveces</surname><given-names>Andr&#x000e9;s</given-names></name><degrees>M.D.</degrees><xref rid="A1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Ray</surname><given-names>Colleen M.</given-names></name><degrees>Ph.D.</degrees><xref rid="A1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Niolon</surname><given-names>Phyllis Holditch</given-names></name><degrees>Ph.D.</degrees><xref rid="A1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Massetti</surname><given-names>Greta M.</given-names></name><degrees>Ph.D.</degrees><xref rid="A1" ref-type="aff">a</xref></contrib></contrib-group><aff id="A1"><label>a</label>Division of Violence Prevention, National Center for Injury
Prevention and Control, Centers for Disease Control and Prevention, Atlanta,
Georgia</aff><aff id="A2"><label>b</label>Georgia Health Policy Center, Georgia State University,
Atlanta, Georgia</aff><aff id="A3"><label>c</label>Division of Overdose Prevention, National Center for Injury
Prevention and Control, Centers for Disease Control and Prevention, Atlanta,
Georgia</aff><author-notes><fn fn-type="con" id="FN1"><p id="P1">Contributor&#x02019;s Statement</p><p id="P2">Dr. Swedo coordinated the project, conceptualized and designed the
study, accessed and verified data analysis, drafted the initial manuscript,
and reviewed and revised the final manuscript.</p><p id="P3">Dr. Anderson conducted the data analysis, created tables and figures,
drafted the initial manuscript, and reviewed and revised the final
manuscript.</p><p id="P4">Drs. Okwori, DePadilla, Clayton, Villaveces, Ray, Niolon, and
Massetti provided subject matter expertise on methodology, data sources,
substance use, and violence; drafted the initial manuscript; and reviewed
and revised the final manuscript.</p><p id="P5">All authors approved the final manuscript as submitted and agree to
be accountable for all aspects of the work.</p></fn><corresp id="CR1"><label>*</label>Address correspondence to: Elizabeth A. Swedo,
M.D., Division of Violence Prevention, National Center for Injury Prevention and
Control, Centers for Disease Control and Prevention, 4770 Buford Highway NE,
Mailstop S106-10, Atlanta, GA 30341. <email>eswedo@cdc.gov</email> (E.A.
Swedo).</corresp></author-notes><pub-date pub-type="nihms-submitted"><day>7</day><month>2</month><year>2025</year></pub-date><pub-date pub-type="ppub"><month>1</month><year>2025</year></pub-date><pub-date pub-type="epub"><day>28</day><month>9</month><year>2024</year></pub-date><pub-date pub-type="pmc-release"><day>28</day><month>2</month><year>2025</year></pub-date><volume>76</volume><issue>1</issue><fpage>52</fpage><lpage>61</lpage><abstract id="ABS1"><sec id="S1"><title>Purpose:</title><p id="P6">Adverse childhood experiences (ACEs) increase the risk for poor
mental health (MH) and substance use. We describe relationships between
adolescents&#x02019; ACEs, substance use, and poor MH occurring during the
COVID-19 pandemic.</p></sec><sec id="S2"><title>Methods:</title><p id="P7">We conducted a secondary analysis of data among U.S. high school
students aged &#x0003c;18 years, who participated in the nationally
representative Adolescent Behaviors and Experiences Survey. Data were
collected from January to June 2021. Bivariate and multivariable analyses
assessed associations between individual ACEs (physical, emotional abuse by
parent or caregiver, parent or caregiver job loss, food insecurity, sexual
violence, physical dating violence, or cyber bullying) and cumulative ACEs
(0, 1&#x02013;2, 3, 4+) experienced during the pandemic and substance use;
stratified analyses assessed effects of poor MH on associations between ACEs
and substance use.</p></sec><sec id="S3"><title>Results:</title><p id="P8">Use of all substances was higher among adolescents with ACEs,
particularly those who experienced both ACEs and poor MH during the COVID-19
pandemic. Prevalence of substance use was especially high among adolescents
exposed to any sexual violence or physical dating violence. Compared to
adolescents without ACEs, a higher percentage of adolescents with 4+ ACEs
reported current use of alcohol (adjusted prevalence ratio [aPR], 5.32) or
marijuana (aPR, 5.86), misuse of prescription pain medications (aPR, 8.82),
binge drinking (aPR, 7.70), and increased alcohol (aPR, 6.54) or drug (aPR,
7.09) use during the pandemic.</p></sec><sec id="S4"><title>Discussion:</title><p id="P9">The individual and combined impact of ACEs and MH on adolescent
substance use reinforce the need for trauma-informed care and primary
prevention of ACEs to prevent and mitigate poor MH and substance use among
adolescents.</p></sec></abstract><kwd-group><kwd>Adverse childhood experiences</kwd><kwd>Mental health</kwd><kwd>Substance use</kwd><kwd>Adolescents</kwd><kwd>Pandemic</kwd></kwd-group></article-meta></front><body><p id="P10">Adverse childhood experiences, or ACEs, are preventable, potentially traumatic
events that occur in childhood [<xref rid="R1" ref-type="bibr">1</xref>]. The COVID-19
pandemic and associated restrictions implemented to slow the spread of disease led to
significant disruptions in adolescents&#x02019; academic and personal lives [<xref rid="R2" ref-type="bibr">2</xref>] and raised concerns that ACEs could increase
during the public health emergency [<xref rid="R3" ref-type="bibr">3</xref>]. While
exact comparisons of ACEs prevalence both before and during the COVID-19 pandemic are
difficult to find, a recent study of adolescents found that ACEs were common during the
COVID-19 pandemic, with 55.1% of youth reporting emotional abuse and 11.3% reporting
physical abuse by a parent or caregiver during the pandemic [<xref rid="R2" ref-type="bibr">2</xref>]. A national, longitudinal survey conducted twice during
the COVID-19 pandemic found that between wave 1 (the fall of 2020) and wave 2 (the
spring of 2021) of the study, 17.6% of respondents experienced one new ACE, 6.1%
experienced 2 new ACEs, and 2.7% experienced 4 or more new ACEs [<xref rid="R4" ref-type="bibr">4</xref>].</p><p id="P11">There is an established link between ACEs and increased risk for smoking,
alcohol use, and illicit drug use in adolescence [<xref rid="R5" ref-type="bibr">5</xref>&#x02013;<xref rid="R7" ref-type="bibr">7</xref>] and adulthood [<xref rid="R8" ref-type="bibr">8</xref>&#x02013;<xref rid="R15" ref-type="bibr">15</xref>].
In addition to worries regarding ACEs, concerns about potential increases in
adolescents&#x02019; substance use during the COVID-19 pandemic emerged [<xref rid="R16" ref-type="bibr">16</xref>]. In 2021, 7.0% or 1.8 million adolescents aged
12&#x02013;17 reported any alcohol use and 3.8% or nearly one million adolescents
reported binge drinking in the past month [<xref rid="R17" ref-type="bibr">17</xref>].
During the same period, 14.1% or 3.7 million adolescents reported past-year illicit drug
use, and 8.5% or 2.2 million adolescents reported a drug or alcohol use disorder in the
past year. Although estimates of illicit drug use for this same age group did not
increase consistently between 2019 and 2022 [<xref rid="R17" ref-type="bibr">17</xref>],
electronic health record data showed that mean weekly emergency department visits for
all drug overdoses were 10% higher in the fall of 2022 compared to fall of 2019 among
adolescents aged 12&#x02013;17 years [<xref rid="R18" ref-type="bibr">18</xref>];
cannabis-related emergency department visits for children aged 11&#x02013;14 years
increased in 2020, 2021, and 2022, compared with 2019 [<xref rid="R19" ref-type="bibr">19</xref>]; and mortality data showed that fatal overdoses among those aged
14&#x02013;18 increased by 94% from 2019 to 2020 and 20% from 2020 to 2021 [<xref rid="R20" ref-type="bibr">20</xref>]. Reviews of multiple studies of data collected
during the pandemic concluded that the results were mixed or unclear as to whether
substance use among adolescents had increased or decreased during COVID-19 [<xref rid="R21" ref-type="bibr">21</xref>]. Results from national surveys of high school
students showed that, in 2021, current use of alcohol [<xref rid="R22" ref-type="bibr">22</xref>], lifetime and past-year use of illicit drugs [<xref rid="R22" ref-type="bibr">22</xref>,<xref rid="R23" ref-type="bibr">23</xref>], and binge
drinking in the previous 2 weeks [<xref rid="R23" ref-type="bibr">23</xref>] decreased
from the previous year, and the current misuse of prescription opioids was stable [<xref rid="R22" ref-type="bibr">22</xref>].</p><p id="P12">The COVID-19 pandemic had an undeniable impact on stress and MH concerns among
children and adolescents [<xref rid="R22" ref-type="bibr">22</xref>,<xref rid="R24" ref-type="bibr">24</xref>]. A recent systematic review documented increased
symptomology of anxiety, depression, attention-deficit/hyperactivity disorder, sleep
disorders, and eating disorders during the COVID-19 pandemic for adolescents [<xref rid="R24" ref-type="bibr">24</xref>]. Adolescents may have been particularly
vulnerable during this period due to the combined stress of decreased interaction with
peers, transitions to virtual learning, adolescent development, routine disruptions, and
family stressors and conflict [<xref rid="R25" ref-type="bibr">25</xref>,<xref rid="R26" ref-type="bibr">26</xref>]. Recent studies have demonstrated compounding effects of
ACEs and pandemic-related stress on adolescent MH [<xref rid="R27" ref-type="bibr">27</xref>,<xref rid="R28" ref-type="bibr">28</xref>]. Verlenden et al.&#x02019;s
2024 study of longitudinal COVID-19 survey data built evidence for a possible causal
relationship between ACEs, pandemic-related stress, and subsequent depressive symptoms,
showing significant direct effects of both pandemic-related stress and ACEs reported in
Wave 1 on subsequent depressive symptoms reported at Wave 2 [<xref rid="R28" ref-type="bibr">28</xref>].</p><p id="P13">To date, no study has assessed the relationship between ACEs experienced during
the pandemic and substance use among adolescents. Moreover, very few studies have
examined the combined impact of ACEs and poor mental health on substance use in
adolescents [<xref rid="R29" ref-type="bibr">29</xref>&#x02013;<xref rid="R31" ref-type="bibr">31</xref>]. The objective of the present study was to: (1) describe
the relationship between adolescents&#x02019; exposure to individual and cumulative ACEs
during the pandemic and substance use during the COVID-19 pandemic, and (2) understand
the influence of poor mental health on associations between ACEs and substance use in
adolescents.</p><sec id="S5"><title>Methods</title><sec id="S6"><title>Participants</title><p id="P14">This study used data from the 2021 Adolescent Behavior and Experiences
Survey (ABES), conducted by the Centers for Disease Control and Prevention (CDC)
during January&#x02013;June 2021. ABES was a one-time, probability-based web
survey of U.S. high school students in grades 9 through 12. ABES used a
stratified, 3-stage cluster sample design to obtain a nationally representative
sample of public- and private-school students in the 50 states and District of
Columbia (N = 7,705; 128 schools). School response rate was 38%, student
response rate was 48%, and overall response rate was 18%. Data were weighted to
account for school and student nonresponse and oversampling of Black and
Hispanic students. ABES study protocol was reviewed and approved by
institutional review boards at CDC and ICF International Inc., CDC&#x02019;s
survey contractor. Additional ABES information has been previously published,
including study protocol [<xref rid="R32" ref-type="bibr">32</xref>], and the
prevalence of individual and cumulative ACEs [<xref rid="R2" ref-type="bibr">2</xref>,<xref rid="R27" ref-type="bibr">27</xref>], substance use [<xref rid="R33" ref-type="bibr">33</xref>], and poor MH [<xref rid="R34" ref-type="bibr">34</xref>] experienced during the pandemic by
participants.</p></sec><sec id="S7"><title>Survey content</title><p id="P15">Our exposure of interest was the ACEs experienced during the COVID-19
pandemic. Adolescents self-reported on experiences of adversities &#x0201c;during
the COVID-19 pandemic&#x0201d; (physical abuse by a parent or caregiver,
emotional abuse by a parent or caregiver, parent or caregiver job loss, or food
insecurity) or during the past 12 months (sexual violence by any perpetrator,
physical dating violence, or cyberbullying; <xref rid="SD1" ref-type="supplementary-material">Table S1</xref>). Given the timing of the
widespread onset of the U.S. COVID-19 pandemic (March 2020) and ABES survey
administration (January&#x02013;June 2021), the &#x0201c;past 12 months&#x0201d;
reference period largely reflected experiences during the COVID-19 pandemic,
overlapping considerably with the time period for the &#x0201c;during the
COVID-19 pandemic&#x0201d; questions. All relevant measures from ABES were
included as ACEs experienced during the COVID-19 pandemic for this analysis.</p><p id="P16">Students self-reported their current substance use in the past 30 days
(including any alcohol use, binge drinking, marijuana use, or prescription
opioid misuse) and whether their alcohol or drug use increased during the
COVID-19 pandemic (<xref rid="SD2" ref-type="supplementary-material">Table
S2</xref>). Poor MH during the pandemic was measured by combining 2 items:
self-reported MH from the past 30 days and during the COVID-19 pandemic (<xref rid="SD2" ref-type="supplementary-material">Table S2</xref>).</p></sec><sec id="S8"><title>Statistical analysis</title><p id="P17">The final analytic sample included 4,374 high school students aged
&#x0003c;18 years (to align with the focus on ACEs), with complete data on
analytic variables of interest. Students with missing data on variables of
interest (n = 2,261) and/or who were &#x02265;18 years (n = 1,070) were excluded
from the analysis. Exposure to ACEs during the pandemic was examined by
individual type (physical abuse, emotional abuse, sexual violence, physical
dating violence, cyberbullying, parent lost job, or food insecurity), category
(experiencing abuse by a parent [physical abuse and emotional abuse],
experiencing other violence [sexual violence, physical dating violence, or
cyberbullying], family economic challenges [parent lost job and food
insecurity]), and the cumulative number of ACEs (0, 1&#x02013;2, 3, or 4+). We
calculated weighted pairwise prevalence estimates and corresponding 95%
confidence intervals (CIs) for recent ACE exposure (type, category, and
cumulative number) by each type of substance used. Adjusted prevalence ratios
(aPRs) with 95% CIs were calculated using Poisson regression with robust
standard errors (SEs) to examine associations between recent ACE exposure and
substance use, adjusted for adolescent sex, race and ethnicity, age, sexual
identity, and method of school instruction (i.e., virtual, inperson, or hybrid)
at the time the school was recruited to participate in ABES. To examine the
relative contribution of different ACEs, a second set of aPRs for recent ACE
exposure and substance use was also calculated, which adjusted for the
aforementioned sociodemographics and each additional individual ACE.</p><p id="P18">We also examined whether poor MH affected substance use among those who
were exposed to each recent ACE type or category. We calculated weighted
pairwise prevalence estimates for the presence of self-reported poor MH for each
substance use outcome among those who were exposed to each ACE type or category.
APRs with 95% CIs were calculated using Poisson regression with robust SE to
examine links between poor MH and substance use among those exposed to each ACE,
adjusting for the sociodemographics noted above. Finally, we examined how poor
MH impacted the relationship between cumulative ACEs and substance use. To do
so, we stratified by the presence of each substance use outcome and calculated
the mean and the SE for cumulative number of ACEs among those with and without
poor MH. Significant differences in mean ACEs reported by those with and without
poor MH were assessed using t-tests; no additional covariates were included. We
examined poor MH for the time frame that aligned with the substance use (i.e.,
during the past 30 days or during the COVID-19 pandemic) outcome of interest.
Analyses were conducted using SAS statistical software (version 9.4, SAS
Institute), accounting for complex survey design.</p></sec></sec><sec id="S9"><title>Results</title><p id="P19">Associations between specific ACEs during the pandemic and substance use
varied by individual ACE type and substance (<xref rid="T1" ref-type="table">Table
1</xref>). Use of all types of substances was higher among individuals exposed
to any individual ACE during the pandemic compared to those who did not report
exposure to an individual ACE during the pandemic. The prevalence of substance use
was especially high among individuals exposed to any sexual violence or physical
dating violence during the pandemic&#x02014;30.1% of adolescents who experienced any
sexual violence in the past 12 months and 29.6% of adolescents who experienced any
physical dating violence in the past 12 months reported increased use of drugs
during the COVID-19 pandemic. When adjusted for sociodemographics, all individual
ACEs during the pandemic were associated with current or increased use of most
included substances. After controlling for both sociodemographics and exposure to
other ACEs during the pandemic, there was variation in individual ACEs&#x02019;
associations with substance use (<xref rid="T1" ref-type="table">Table 1</xref>).
Emotional abuse during the pandemic was consistently associated with all types of
substance use, after controlling for both sociodemographics and exposure to other
ACEs during the pandemic.</p><p id="P20">The magnitude and significance of associations between ACE categories
(experiencing abuse by a parent during the pandemic, experiencing other violence
during the pandemic, or family economic challenges during the pandemic) and
substance use differed for individual outcomes (<xref rid="T2" ref-type="table">Table 2</xref>). All ACE categories were associated with current or increased
use of substances in models adjusted for sociodemographics. In models controlling
for sociodemographics and exposure to other ACE categories during the pandemic,
experiencing abuse by a parent during the pandemic generally had the highest
prevalence ratios for use of each substance (aPR range, 1.88&#x02013;2.73), apart
from current binge drinking, which was most strongly associated with experiences of
other forms of violence during the pandemic (aPR, 2.42; 95% CI, 1.82&#x02013;3.20).
Family economic challenges during the pandemic had smaller, but significant,
associations with substance use in models adjusted for sociodemographics; when
controlling for experiences of other ACEs categories, family economic challenges
were not significantly associated with current binge drinking, current prescription
opioid misuse, or increased drug use during the COVID-19 pandemic.</p><p id="P21">A strong dose-response relationship was observed between cumulative exposure
to ACEs during the pandemic and substance use (<xref rid="F1" ref-type="fig">Figure
1</xref>). Experiencing even 1&#x02013;2 ACEs during the pandemic (compared to 0
ACEs during the pandemic) doubled or tripled the prevalence of substance use (aPR
range of 2.34 for current alcohol use to 3.51 for current prescription opioid
misuse). Compared to adolescents who did not experience ACEs during the pandemic,
adolescents who experienced 4+ ACEs during the pandemic had 5.32 times (95% CI,
3.85&#x02013;7.37) higher prevalence of current alcohol use, 7.70 times (95% CI,
4.84&#x02013;12.23) higher prevalence of binge drinking, 6.54 times (95% CI,
4.31&#x02013;9.95) higher prevalence of reporting increased use of alcohol during the
COVID-19 pandemic, 5.86 times (95% CI 3.98&#x02013;8.64) higher prevalence of current
marijuana use, 8.82 times (95% CI 3.62&#x02013;21.49) higher prevalence of current
prescription pain medication misuse, and 7.09 times (95% CI 4.55&#x02013;11.05)
higher prevalence of reporting increased use of drugs during the COVID-19 pandemic
compared to adolescents who did not experience ACEs during the pandemic.</p><p id="P22">The mean number of ACEs during the pandemic was higher among students with
poor MH compared to students without poor MH (<xref rid="T3" ref-type="table">Table
3</xref>). The mean number of ACEs during the pandemic was also higher among
students reporting the use of each substance compared to those who did not. The mean
number of ACEs experienced during the pandemic was the highest among adolescents
with both poor MH and substance use.</p><p id="P23">Among adolescents who experienced each ACE during the pandemic, poor MH was
associated with increased prevalence of nearly all types of substance use (<xref rid="T4" ref-type="table">Table 4</xref>). The absolute prevalence of substance
use was especially notable among adolescents who experienced both poor MH and any
sexual violence: 51.7% reported current alcohol use, 30.7% reported current binge
drinking, 32.8% reported increased alcohol use during the COVID-19 pandemic, 34.1%
reported current marijuana use, and 31.1% reported increased drug use during the
COVID-19 pandemic. Similarly, adolescents with both poor MH and the physical dating
violence ACE reported high levels of alcohol use as follows: 53.0% reported current
alcohol use, 32.7% reported current binge drinking, and 38.5% reported their alcohol
use increased during the pandemic. The strongest association between an individual
ACE, poor MH, and substance use was observed for parental job loss and increased
drug use during COVID-19, with these adolescents having 3.52 times (95% CI
1.97&#x02013;6.31) higher prevalence of reporting increased drug use than adolescents
who experienced parental job loss during the pandemic but did not report poor
MH.</p></sec><sec id="S10"><title>Discussion</title><p id="P24">Experiences of individual and cumulative ACEs during the pandemic were
strongly associated with current or increased use of substances among U.S.
adolescents. Experiencing even 1&#x02013;2 ACEs during the pandemic doubled or
tripled the prevalence of substance use; experiencing 4+ ACEs during the pandemic
increased prevalence of current or increased substance use by a factor of
5&#x02013;9. Similar to previous studies, we found that adolescents experiencing ACEs
during the pandemic had a greater prevalence of reporting poor MH compared to those
who did not experience ACEs during the pandemic [<xref rid="R27" ref-type="bibr">27</xref>]. We observed a striking multiplicative effect on substance use for
adolescents who experienced ACEs during the pandemic and also reported poor MH
compared to those without these exposures; this suggests that prevention and
mitigation of the effects of ACEs on MH may help to reduce adolescent substance use.
Alcohol and marijuana use were especially prevalent among adolescents who
experienced sexual violence or physical dating violence, alone and in combination
with poor MH. Consistent with previous studies [<xref rid="R35" ref-type="bibr">35</xref>], we found different substance use patterns emerged for individual
ACE types and categories (e.g., experiencing abuse by a parent, other violence,
family economic challenges), with resultant implications for clinicians and public
health officials working to prevent and mitigate harms related to substance use.</p><p id="P25">Study results for food insecurity and cyberbullying during the pandemic
lacked consistent associations between these ACEs and substance use, when
controlling for other ACEs. Although both food insecurity and cyberbullying during
the pandemic had some significant associations with substance use when controlling
for demographic characteristics, the associations were no longer significant after
controlling for other ACEs during the pandemic. These results suggest that food
insecurity and cyberbullying experienced during the pandemic were not independently
associated with substance use but may be antecedents of other variables that
contributed directly to substance use. In addition, poor MH influenced the
association between both food insecurity and cyberbullying during the pandemic and
substance use. Taken together, the pattern of findings for food insecurity and
cyberbullying during the pandemic suggest that they do not play a direct role in
increasing risk for substance use, but may interact with other factors&#x02014;such
as other ACEs and poor MH&#x02014;to contribute to risk. These results warrant
further exploration of the role that food insecurity and cyberbullying may play in
exacerbating the influence of ACEs and poor MH.</p><p id="P26">Our findings that ACEs during the pandemic were strongly associated with
current or increased substance use are consistent with other studies conducted among
adolescents [<xref rid="R5" ref-type="bibr">5</xref>,<xref rid="R6" ref-type="bibr">6</xref>,<xref rid="R36" ref-type="bibr">36</xref>] and adults [<xref rid="R37" ref-type="bibr">37</xref>,<xref rid="R38" ref-type="bibr">38</xref>]. Few
studies have assessed ACEs in adolescent populations, and the striking association
between ACEs during the pandemic and substance use, especially when coupled with
poor MH, highlights a crucial opportunity for prevention and intervention [<xref rid="R39" ref-type="bibr">39</xref>]. Most ACEs studies have examined MH
outcomes and substance use as separate [<xref rid="R40" ref-type="bibr">40</xref>,<xref rid="R41" ref-type="bibr">41</xref>] or co-occurrent [<xref rid="R42" ref-type="bibr">42</xref>,<xref rid="R43" ref-type="bibr">43</xref>]
outcomes; few studies exist looking at the moderating or mediating role of poor MH
on ACEs&#x02019; associations with substance use [<xref rid="R29" ref-type="bibr">29</xref>&#x02013;<xref rid="R31" ref-type="bibr">31</xref>,<xref rid="R35" ref-type="bibr">35</xref>]. Douglas et al.&#x02019;s study of adults found that,
after exposure to ACEs, the development of mood and anxiety disorders usually
preceded the onset of a substance use disorder by approximately 3 years [<xref rid="R13" ref-type="bibr">13</xref>]. The associations found during our
study&#x02019;s shorter timeframe suggest that there may not always be a long delay
between experiences of ACEs, poor MH, and substance use. A 2020 study of U.S. adults
reporting high-intensity binge drinking found that the association between ACEs and
extreme binge drinking was only partially mediated through psychiatric disorders
[<xref rid="R29" ref-type="bibr">29</xref>]. Similarly, Tang et al. found that
internalizing and, particularly, externalizing symptoms partially mediated the
association between ACEs and prescription opioid misuse in U.S. adults [<xref rid="R31" ref-type="bibr">31</xref>]. Taken together, these findings suggest a
complex relationship between ACEs, poor MH, and increased risk for substance use or
use disorders. While adolescents who reported ACEs during the pandemic and poor MH
often had higher rates of substance use in this analysis, substance use was also
common among those who experienced ACEs during the pandemic without reporting poor
MH. This suggests there are also unique contributors to the relationship between
ACEs and substance use beyond MH.</p><p id="P27">Clinicians and others who work with adolescents are uniquely poised to
recognize and mitigate the impact of ACEs on both MH and substance use. Over 50% of
young adults with substance use disorders have at least one co-occurring MH
condition [<xref rid="R17" ref-type="bibr">17</xref>], and the presence of comorbid
disorders worsens substance use outcomes [<xref rid="R44" ref-type="bibr">44</xref>]. The strong associations and comorbid occurrence of ACEs with poor MH
and substance use reinforces the need for appropriate, trauma-informed responses in
clinical and nonclinical settings [<xref rid="R39" ref-type="bibr">39</xref>].
Delivery of services, however, requires appropriate knowledge and training of
providers, awareness of ACEs, and minimization of barriers for disclosure of
events.</p><p id="P28">This constellation of problems shares risk and protective factors, meaning
that upstream strategies can prevent and mitigate the impact of ACEs, substance use,
and poor MH. Foundationally, establishing safe, stable, nurturing relationships and
environments (SSNREs) for all children prevents ACEs [<xref rid="R1" ref-type="bibr">1</xref>], decreases the impact of ACEs on health risk behaviors when they
occur [<xref rid="R45" ref-type="bibr">45</xref>], and reduces prevalence of
substance use [<xref rid="R46" ref-type="bibr">46</xref>] or experiencing poor MH
[<xref rid="R47" ref-type="bibr">47</xref>]. CDC has developed a suite of
technical packages and resources to share evidence-based strategies that prevent
ACEs and promote SSNREs [<xref rid="R1" ref-type="bibr">1</xref>,<xref rid="R48" ref-type="bibr">48</xref>]. Such strategies include strengthening economic
supports to families, changing social norms to support parents and encourage
positive parenting, provision of quality childcare and early education, enhanced
parenting skills to promote healthy child development, and intervening to lessen
harms and prevent future risk [<xref rid="R1" ref-type="bibr">1</xref>,<xref rid="R48" ref-type="bibr">48</xref>]. Preventing ACEs can prevent substance use
and MH problems in the current generation; treating substance use and MH problems
can prevent ACEs for the next generation.</p><p id="P29">This study was subject to several limitations. First, because ABES is a
cross-sectional survey, causal inferences cannot be made. Second, the response rate
(18%) for ABES is lower than other school-based surveys [<xref rid="R32" ref-type="bibr">32</xref>]. However, nonresponse bias analyses revealed that
weighting adjustments minimized the potential for nonresponse bias in the ABES
sample [<xref rid="R32" ref-type="bibr">32</xref>]. Third, this study included only
7 ACEs experienced during the pandemic [<xref rid="R49" ref-type="bibr">49</xref>];
inclusion of more ACEs might have resulted in a different score distribution and
differential results for which ACEs are most associated with substance use
behaviors. Moreover, the use of count or dichotomous ACE variables does not capture
the complexity and nuances of experiences that individuals may encounter during
childhood. This limitation arises from the fact that ACEs can follow latent patterns
or exhibit nonadditive characteristics, which are not adequately captured by binary
categorization methods. Fourth, this analysis did not have the ability to directly
assess experiences or impact of the pandemic, and instead included available ACE
measures that adolescents commonly experience. Lastly, ACE measures available in the
ABES were of past 12 months or during the timeframe of the pandemic; measures for
lifetime childhood exposure to ACEs were not available. Examination of ACEs over the
lifetime may have differential results on substance use behaviors among youth
exposed to ACEs earlier in childhood. Associations between ACEs experienced during
the pandemic and outcomes may reflect the impact of both ACEs during the pandemic
and the cumulative toll of lifetime ACEs; given the survey contents, we were unable
to account for lifetime ACEs to tease apart the specific impact of ACEs during the
pandemic versus ACEs experienced prior to the pandemic.</p><sec id="S11"><title>Conclusions</title><p id="P30">ACEs, substance use, and poor MH were common among U.S. adolescents
during the COVID-19 pandemic. Experiences of individual and cumulative ACEs
during the pandemic were strongly associated with current or increased use of
substances, particularly among adolescents experiencing poor MH. The strong
associations and comorbid occurrence of ACEs with poor MH and substance use
emphasize the need for trauma-informed care in all health care settings,
particularly for adolescents experiencing co-occurrent poor MH and substance
use. Targeting shared risk factors for ACEs, substance use, and poor
MH&#x02014;through primary prevention of ACEs and promotion of SSNREs&#x02014;is a
critical public health priority for improving adolescent and adult health.</p></sec></sec><sec sec-type="supplementary-material" id="SM1"><title>Supplementary Material</title><supplementary-material id="SD1" position="float" content-type="local-data"><label>S1</label><media xlink:href="NIHMS2049072-supplement-S1.docx" id="d67e476" position="anchor"/></supplementary-material><supplementary-material id="SD2" position="float" content-type="local-data"><label>S2</label><media xlink:href="NIHMS2049072-supplement-S2.docx" id="d67e479" position="anchor"/></supplementary-material></sec></body><back><ack id="S12"><title>Funding Sources</title><p id="P31">CDC funded the design and conduct of the study; collection, management,
analysis, and interpretation of secondary data; preparation, review, or approval of
the manuscript; and decision to submit the manuscript for publication.</p></ack><fn-group><fn fn-type="COI-statement" id="FN2"><p id="P32"><bold>Conflicts of interest:</bold> The authors have no conflicts of
interest to declare.</p></fn><fn id="FN3"><p id="P33"><bold>Disclaimer:</bold> The findings and conclusions in this report are
those of the authors and do not necessarily represent the official position of
CDC.</p></fn><fn id="FN4"><p id="P34">Supplementary Datas</p><p id="P35">Supplementary data related to this article can be found at <ext-link xlink:href="10.1016/j.jadohealth.2024.07.030" ext-link-type="doi">https://doi.org/10.1016/j.jadohealth.2024.07.030</ext-link>.</p></fn></fn-group><ref-list><title>References</title><ref id="R1"><label>[1]</label><mixed-citation publication-type="book"><collab>Centers for Disease Control and
Prevention</collab>. <source>Preventing adverse childhood experiences: Leveraging the best available evidence</source>. <publisher-loc>Atlanta,
GA</publisher-loc>: <publisher-name>National Center for Injury Prevention
and Control, Centers for Disease Control and Prevention</publisher-name>;
<year>2019</year>.</mixed-citation></ref><ref id="R2"><label>[2]</label><mixed-citation publication-type="journal"><name><surname>Krause</surname><given-names>KH</given-names></name>, <name><surname>Verlenden</surname><given-names>JV</given-names></name>, <name><surname>Szucs</surname><given-names>LE</given-names></name>, <etal/>
<article-title>Disruptions to school and home life among high school students
during the COVID-19 pandemic&#x02014;adolescent behaviors and experiences
survey, United States, January&#x02013;June 2021</article-title>.
<source>MMWR Suppl</source>
<year>2022</year>;<volume>71</volume>:<fpage>28</fpage>.<pub-id pub-id-type="pmid">35358164</pub-id>
</mixed-citation></ref><ref id="R3"><label>[3]</label><mixed-citation publication-type="journal"><name><surname>Racine</surname><given-names>NM</given-names></name>, <name><surname>Macmillan</surname><given-names>HL</given-names></name>, <name><surname>Madigan</surname><given-names>S</given-names></name>. <article-title>Understanding and addressing adverse childhood
experiences in the face of the COVID-19 pandemic</article-title>.
<source>Eur Child Adolesc Psychiatr</source>
<year>2024</year>;<volume>33</volume>:<fpage>945</fpage>&#x02013;<lpage>7</lpage>.</mixed-citation></ref><ref id="R4"><label>[4]</label><mixed-citation publication-type="journal"><name><surname>Hertz</surname><given-names>M</given-names></name>, <name><surname>Heim Viox</surname><given-names>M</given-names></name>, <name><surname>Massetti</surname><given-names>GM</given-names></name>, <etal/>
<article-title>Adverse childhood experiences among US adolescents over the
course of the COVID-19 pandemic</article-title>. <source>Pediatrics</source>
<year>2023</year>;<volume>151</volume>:<fpage>e2022060799</fpage>.<pub-id pub-id-type="pmid">37158017</pub-id>
</mixed-citation></ref><ref id="R5"><label>[5]</label><mixed-citation publication-type="journal"><name><surname>Afifi</surname><given-names>TO</given-names></name>, <name><surname>Taillieu</surname><given-names>T</given-names></name>, <name><surname>Salmon</surname><given-names>S</given-names></name>, <etal/>
<article-title>Adverse childhood experiences (ACEs), peer victimization, and
substance use among adolescents</article-title>. <source>Child Abuse Negl</source>
<year>2020</year>;<volume>106</volume>:<fpage>104504</fpage>.<pub-id pub-id-type="pmid">32402816</pub-id>
</mixed-citation></ref><ref id="R6"><label>[6]</label><mixed-citation publication-type="journal"><name><surname>Chatterjee</surname><given-names>D</given-names></name>, <name><surname>McMorris</surname><given-names>B</given-names></name>, <name><surname>Gower</surname><given-names>AL</given-names></name>, <etal/>
<article-title>Adverse childhood experiences and early initiation of marijuana
and alcohol use: The potential moderating effects of internal
assets</article-title>. <source>Subst Use Misuse</source>
<year>2018</year>;<volume>53</volume>:<fpage>1624</fpage>&#x02013;<lpage>32</lpage>.<pub-id pub-id-type="pmid">29364764</pub-id>
</mixed-citation></ref><ref id="R7"><label>[7]</label><mixed-citation publication-type="journal"><name><surname>Forster</surname><given-names>M</given-names></name>, <name><surname>Gower</surname><given-names>AL</given-names></name>, <name><surname>Borowsky</surname><given-names>IW</given-names></name>, <name><surname>McMorris</surname><given-names>BJ</given-names></name>. <article-title>Associations between adverse childhood experiences,
student-teacher relationships, and non-medical use of prescription
medications among adolescents</article-title>. <source>Addict Behav</source>
<year>2017</year>;<volume>68</volume>:<fpage>30</fpage>&#x02013;<lpage>4</lpage>.<pub-id pub-id-type="pmid">28088740</pub-id>
</mixed-citation></ref><ref id="R8"><label>[8]</label><mixed-citation publication-type="journal"><name><surname>Felitti</surname><given-names>VJ</given-names></name>, <name><surname>Anda</surname><given-names>RF</given-names></name>, <name><surname>Nordenberg</surname><given-names>D</given-names></name>, <etal/>
<article-title>Relationship of childhood abuse and household dysfunction to many
of the leading causes of death in adults: The adverse childhood experiences
(ACE) study</article-title>. <source>Am J Prev Med</source>
<year>1998</year>;<volume>14</volume>:<fpage>245</fpage>&#x02013;<lpage>58</lpage>.<pub-id pub-id-type="pmid">9635069</pub-id>
</mixed-citation></ref><ref id="R9"><label>[9]</label><mixed-citation publication-type="journal"><name><surname>Dube</surname><given-names>SR</given-names></name>, <name><surname>Felitti</surname><given-names>VJ</given-names></name>, <name><surname>Dong</surname><given-names>M</given-names></name>, <etal/>
<article-title>Childhood abuse, neglect, and household dysfunction and the risk
of illicit drug use: The adverse childhood experiences
study</article-title>. <source>Pediatrics</source>
<year>2003</year>;<volume>111</volume>:<fpage>564</fpage>&#x02013;<lpage>72</lpage>.<pub-id pub-id-type="pmid">12612237</pub-id>
</mixed-citation></ref><ref id="R10"><label>[10]</label><mixed-citation publication-type="journal"><name><surname>Dube</surname><given-names>SR</given-names></name>, <name><surname>Miller</surname><given-names>JW</given-names></name>, <name><surname>Brown</surname><given-names>DW</given-names></name>, <etal/>
<article-title>Adverse childhood experiences and the association with ever using
alcohol and initiating alcohol use during adolescence</article-title>.
<source>J Adolesc Health</source>
<year>2006</year>;<volume>38</volume>:<fpage>444.e1</fpage>&#x02013;<lpage>444.e10</lpage>.</mixed-citation></ref><ref id="R11"><label>[11]</label><mixed-citation publication-type="journal"><name><surname>Anda</surname><given-names>RF</given-names></name>, <name><surname>Croft</surname><given-names>JB</given-names></name>, <name><surname>Felitti</surname><given-names>VJ</given-names></name>, <etal/>
<article-title>Adverse childhood experiences and smoking during adolescence and
adulthood</article-title>. <source>JAMA</source>
<year>1999</year>;<volume>282</volume>:<fpage>1652</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">10553792</pub-id>
</mixed-citation></ref><ref id="R12"><label>[12]</label><mixed-citation publication-type="journal"><name><surname>Cavanaugh</surname><given-names>CE</given-names></name>, <name><surname>Petras</surname><given-names>H</given-names></name>, <name><surname>Martins</surname><given-names>SS</given-names></name>. <article-title>Gender-specific profiles of adverse childhood
experiences, past year mental and substance use disorders, and their
associations among a national sample of adults in the United
States</article-title>. <source>Soc Psychiatry Psychiatr Epidemiol</source>
<year>2015</year>;<volume>50</volume>:<fpage>1257</fpage>&#x02013;<lpage>66</lpage>.<pub-id pub-id-type="pmid">25701134</pub-id>
</mixed-citation></ref><ref id="R13"><label>[13]</label><mixed-citation publication-type="journal"><name><surname>Douglas</surname><given-names>KR</given-names></name>, <name><surname>Chan</surname><given-names>G</given-names></name>, <name><surname>Gelernter</surname><given-names>J</given-names></name>, <etal/>
<article-title>Adverse childhood events as risk factors for substance
dependence: Partial mediation by mood and anxiety disorders</article-title>.
<source>Addict Behav</source>
<year>2010</year>;<volume>35</volume>:<fpage>7</fpage>&#x02013;<lpage>13</lpage>.<pub-id pub-id-type="pmid">19720467</pub-id>
</mixed-citation></ref><ref id="R14"><label>[14]</label><mixed-citation publication-type="journal"><name><surname>Mersky</surname><given-names>JP</given-names></name>, <name><surname>Topitzes</surname><given-names>J</given-names></name>, <name><surname>Reynolds</surname><given-names>AJ</given-names></name>. <article-title>Impacts of adverse childhood experiences on health,
mental health, and substance use in early adulthood: A cohort study of an
urban, minority sample in the US</article-title>. <source>Child Abuse Negl</source>
<year>2013</year>;<volume>37</volume>:<fpage>917</fpage>&#x02013;<lpage>25</lpage>.<pub-id pub-id-type="pmid">23978575</pub-id>
</mixed-citation></ref><ref id="R15"><label>[15]</label><mixed-citation publication-type="journal"><name><surname>Quinn</surname><given-names>K</given-names></name>, <name><surname>Frueh</surname><given-names>BC</given-names></name>, <name><surname>Scheidell</surname><given-names>J</given-names></name>, <etal/>
<article-title>Internalizing and externalizing factors on the pathway from
adverse experiences in childhood to non-medical prescription opioid use in
adulthood</article-title>. <source>Drug Alcohol Depend</source>
<year>2019</year>;<volume>197</volume>:<fpage>212</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">30849646</pub-id>
</mixed-citation></ref><ref id="R16"><label>[16]</label><mixed-citation publication-type="journal"><name><surname>Silliman Cohen</surname><given-names>RI</given-names></name>, <name><surname>Bosk</surname><given-names>EA</given-names></name>. <article-title>Vulnerable youth and the COVID-19
pandemic</article-title>. <source>Pediatrics</source>
<year>2020</year>;<volume>146</volume>:<fpage>e20201306</fpage>.<pub-id pub-id-type="pmid">32345686</pub-id>
</mixed-citation></ref><ref id="R17"><label>[17]</label><mixed-citation publication-type="book"><collab>Substance Abuse and Mental Health
Services Administration</collab>. <part-title>Key substance use and
mental health indicators in the United States: Results from the 2021
national survey on drug Use and health</part-title>. In: <source>Center for Behavioral Health Statistics and Quality</source>.
<publisher-loc>Rockville, MD</publisher-loc>: <publisher-name>Substance
Abuse and Mental Health Services Administration</publisher-name>;
<year>2022</year>.</mixed-citation></ref><ref id="R18"><label>[18]</label><mixed-citation publication-type="journal"><name><surname>Anderson</surname><given-names>KN</given-names></name>, <name><surname>Johns</surname><given-names>D</given-names></name>, <name><surname>Holland</surname><given-names>K</given-names></name>, <etal/>
<article-title>Changes in emergency department visits Involving mental health
conditions, suicide-related behaviors, and drug overdoses among adolescents
aged 12&#x02013;17 Years, United States, January 2019&#x02013;February
2023</article-title>. <source>MMWR Morb Mortal Wkly Rep</source>
<year>2023</year>;<volume>72</volume>:<fpage>502</fpage>&#x02013;<lpage>12</lpage>.<pub-id pub-id-type="pmid">37167103</pub-id>
</mixed-citation></ref><ref id="R19"><label>[19]</label><mixed-citation publication-type="journal"><name><surname>Roehler</surname><given-names>DR</given-names></name>, <name><surname>Smith</surname><given-names>H</given-names></name>, <name><surname>Radhakrishnan</surname><given-names>L</given-names></name>, <etal/>
<article-title>Cannabis-involved emergency department visits among persons aged
&#x0003c;25 years before and during the COVID-19 pandemic &#x02014; United
States, 2019&#x02013;2022</article-title>. <source>MMWR Morb Mortal Wkly Rep</source>
<year>2023</year>;<volume>72</volume>:<fpage>758</fpage>&#x02013;<lpage>65</lpage>.<pub-id pub-id-type="pmid">37440436</pub-id>
</mixed-citation></ref><ref id="R20"><label>[20]</label><mixed-citation publication-type="journal"><name><surname>Friedman</surname><given-names>J</given-names></name>, <name><surname>Godvin</surname><given-names>M</given-names></name>, <name><surname>Shover</surname><given-names>CL</given-names></name>, <etal/>
<article-title>Trends in drug overdose deaths among US adolescents, January 2010
to June 2021</article-title>. <source>JAMA</source>
<year>2022</year>;<volume>327</volume>:<fpage>1398</fpage>&#x02013;<lpage>400</lpage>.<pub-id pub-id-type="pmid">35412573</pub-id>
</mixed-citation></ref><ref id="R21"><label>[21]</label><mixed-citation publication-type="journal"><name><surname>Zolopa</surname><given-names>C</given-names></name>, <name><surname>Burack</surname><given-names>JA</given-names></name>, <name><surname>O&#x02019;Connor</surname><given-names>RM</given-names></name>, <etal/>
<article-title>Changes in youth mental health, psychological wellbeing, and
substance use during the COVID-19 pandemic: A rapid review</article-title>.
<source>Adolesc Res Rev</source>
<year>2022</year>;<volume>7</volume>:<fpage>161</fpage>&#x02013;<lpage>77</lpage>.<pub-id pub-id-type="pmid">35252542</pub-id>
</mixed-citation></ref><ref id="R22"><label>[22]</label><mixed-citation publication-type="book"><collab>Centers for Disease Control and
Prevention</collab>. <part-title>Youth risk behavior survey: Data summary
&#x00026; trends report, 2011&#x02013;2021</part-title>. In: <source>National Center for HIV VH, STD, and TB Prevention, Division of Adolescent and School Health</source>. <publisher-loc>Atlanta, GA</publisher-loc>:
<publisher-name>Centers for Disease Control and Prevention</publisher-name>;
<year>2023</year>.</mixed-citation></ref><ref id="R23"><label>[23]</label><mixed-citation publication-type="book"><name><surname>Johnston</surname><given-names>LD</given-names></name>, <name><surname>Miech</surname><given-names>RA</given-names></name>, <name><surname>O&#x02019;Malley</surname><given-names>PM</given-names></name>, <etal/>
<source>Monitoring the future national survey results on drug use, 1975&#x02013;2021: Overview, key findings on adolescent drug use</source>.
<publisher-loc>Ann Arbor</publisher-loc>: <publisher-name>Institute for
Social Research, University of Michigan</publisher-name>;
<year>2022</year>.</mixed-citation></ref><ref id="R24"><label>[24]</label><mixed-citation publication-type="journal"><name><surname>Panchal</surname><given-names>U</given-names></name>, <name><surname>Salazar de Pablo</surname><given-names>G</given-names></name>, <name><surname>Franco</surname><given-names>M</given-names></name>, <etal/>
<article-title>The impact of COVID-19 lockdown on child and adolescent mental
health: Systematic review</article-title>. <source>Eur Child Adolesc Psychiatry</source>
<year>2023</year>;<volume>32</volume>:<fpage>1151</fpage>&#x02013;<lpage>77</lpage>.<pub-id pub-id-type="pmid">34406494</pub-id>
</mixed-citation></ref><ref id="R25"><label>[25]</label><mixed-citation publication-type="journal"><name><surname>Lee</surname><given-names>J</given-names></name>. <article-title>Mental health effects of school closures during
COVID-19</article-title>. <source>Lancet Child Adolesc Health</source>
<year>2020</year>;<volume>4</volume>:<fpage>421</fpage>.<pub-id pub-id-type="pmid">32302537</pub-id>
</mixed-citation></ref><ref id="R26"><label>[26]</label><mixed-citation publication-type="journal"><name><surname>Magson</surname><given-names>NR</given-names></name>, <name><surname>Freeman</surname><given-names>JYA</given-names></name>, <name><surname>Rapee</surname><given-names>RM</given-names></name>, <etal/>
<article-title>Risk and protective factors for prospective changes in adolescent
mental health during the COVID-19 pandemic</article-title>. <source>J Youth Adolesc</source>
<year>2021</year>;<volume>50</volume>:<fpage>44</fpage>&#x02013;<lpage>57</lpage>.<pub-id pub-id-type="pmid">33108542</pub-id>
</mixed-citation></ref><ref id="R27"><label>[27]</label><mixed-citation publication-type="journal"><name><surname>Anderson</surname><given-names>KN</given-names></name>. <article-title>Adverse childhood experiences during the COVID-19
pandemic and associations with poor mental health and suicidal behaviors
among high school students&#x02014;adolescent behaviors and experiences
survey, United States, January&#x02013;June 2021</article-title>.
<source>MMWR Morb Mortal Wkly Rep</source>
<year>2022</year>;<volume>71</volume>:<fpage>1301</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="pmid">36227769</pub-id>
</mixed-citation></ref><ref id="R28"><label>[28]</label><mixed-citation publication-type="journal"><name><surname>Verlenden</surname><given-names>J</given-names></name>, <name><surname>Kaczkowski</surname><given-names>W</given-names></name>, <name><surname>Li</surname><given-names>J</given-names></name>, <etal/>
<article-title>Associations between adverse childhood experiences and
pandemic-related stress and the impact on adolescent mental health during
the COVID-19 pandemic</article-title>. <source>J Child Adolesc Trauma</source>
<year>2022</year>;<volume>17</volume>:<fpage>1</fpage>&#x02013;<lpage>15</lpage>.</mixed-citation></ref><ref id="R29"><label>[29]</label><mixed-citation publication-type="journal"><name><surname>Jung</surname><given-names>J</given-names></name>, <name><surname>Rosoff</surname><given-names>DB</given-names></name>, <name><surname>Muench</surname><given-names>C</given-names></name>, <etal/>
<article-title>Adverse childhood experiences are associated with high-intensity
binge drinking behavior in adulthood and mediated by psychiatric
disorders</article-title>. <source>Alcohol Alcohol</source>
<year>2020</year>;<volume>55</volume>:<fpage>204</fpage>&#x02013;<lpage>14</lpage>.<pub-id pub-id-type="pmid">31895420</pub-id>
</mixed-citation></ref><ref id="R30"><label>[30]</label><mixed-citation publication-type="journal"><name><surname>Kim</surname><given-names>Y</given-names></name>, <name><surname>Kim</surname><given-names>K</given-names></name>, <name><surname>Chartier</surname><given-names>KG</given-names></name>, <etal/>
<article-title>Adverse childhood experience patterns, major depressive disorder,
and substance use disorder in older adults</article-title>. <source>Aging Ment Health</source>
<year>2021</year>;<volume>25</volume>:<fpage>484</fpage>&#x02013;<lpage>91</lpage>.<pub-id pub-id-type="pmid">31769297</pub-id>
</mixed-citation></ref><ref id="R31"><label>[31]</label><mixed-citation publication-type="journal"><name><surname>Tang</surname><given-names>S</given-names></name>, <name><surname>Ports</surname><given-names>KA</given-names></name>, <name><surname>Zhang</surname><given-names>K</given-names></name>, <name><surname>Lin</surname><given-names>H-C</given-names></name>. <article-title>Adverse childhood experiences,
internalizing/externalizing symptoms, and associated prescription opioid
misuse: A mediation analysis</article-title>. <source>Prev Med</source>
<year>2020</year>;<volume>134</volume>:<fpage>106034</fpage>.<pub-id pub-id-type="pmid">32087177</pub-id>
</mixed-citation></ref><ref id="R32"><label>[32]</label><mixed-citation publication-type="journal"><name><surname>Rico</surname><given-names>A</given-names></name>, <name><surname>Brener</surname><given-names>ND</given-names></name>, <name><surname>Thornton</surname><given-names>J</given-names></name>, <etal/>
<article-title>Overview and methodology of the adolescent behaviors and
experiences survey&#x02014;United States, January&#x02013;June
2021</article-title>. <source>MMWR Suppl</source>
<year>2022</year>;<volume>71</volume>:<fpage>1</fpage>.</mixed-citation></ref><ref id="R33"><label>[33]</label><mixed-citation publication-type="journal"><name><surname>Brener</surname><given-names>ND</given-names></name>, <name><surname>Bohm</surname><given-names>MK</given-names></name>, <name><surname>Jones</surname><given-names>CM</given-names></name>, <etal/>
<article-title>Use of tobacco products, alcohol, and other substances among high
school students during the COVID-19 pandemic&#x02014;adolescent behaviors and
experiences survey, United States, January&#x02013;June 2021</article-title>.
<source>MMWR Supple</source>
<year>2022</year>;<volume>71</volume>:<fpage>8</fpage>.</mixed-citation></ref><ref id="R34"><label>[34]</label><mixed-citation publication-type="journal"><name><surname>Jones</surname><given-names>SE</given-names></name>, <name><surname>Ethier</surname><given-names>KA</given-names></name>, <name><surname>Hertz</surname><given-names>M</given-names></name>, <etal/>
<article-title>Mental health, suicidality, and connectedness among high school
students during the COVID-19 pandemic&#x02014;adolescent behaviors and
experiences survey, United States, January&#x02013;June 2021</article-title>.
<source>MMWR Suppl</source>
<year>2022</year>;<volume>71</volume>:<fpage>16</fpage>.<pub-id pub-id-type="pmid">35358165</pub-id>
</mixed-citation></ref><ref id="R35"><label>[35]</label><mixed-citation publication-type="journal"><name><surname>Van Zyl</surname><given-names>TL</given-names></name>, <name><surname>O&#x02019;Neill</surname><given-names>T</given-names></name>, <name><surname>Rushe</surname><given-names>T</given-names></name>. <article-title>Distinct psychological profiles linking childhood
adversity and substance misuse in high-risk young adults</article-title>.
<source>J Fam Viol</source>
<year>2023</year>;<volume>38</volume>:<fpage>633</fpage>&#x02013;<lpage>45</lpage>.</mixed-citation></ref><ref id="R36"><label>[36]</label><mixed-citation publication-type="journal"><name><surname>Swedo</surname><given-names>EA</given-names></name>, <name><surname>Sumner</surname><given-names>SA</given-names></name>, <name><surname>de Fijter</surname><given-names>S</given-names></name>, <etal/>
<article-title>Adolescent opioid misuse attributable to adverse childhood
experiences</article-title>. <source>J Pediatr</source>
<year>2020</year>;<volume>224</volume>:<fpage>102</fpage>&#x02013;<lpage>109.e103</lpage>.<pub-id pub-id-type="pmid">32437756</pub-id>
</mixed-citation></ref><ref id="R37"><label>[37]</label><mixed-citation publication-type="journal"><name><surname>Rothman</surname><given-names>EF</given-names></name>, <name><surname>Edwards</surname><given-names>EM</given-names></name>, <name><surname>Heeren</surname><given-names>T</given-names></name>, <name><surname>Hingson</surname><given-names>RW</given-names></name>. <article-title>Adverse childhood experiences predict earlier age of
drinking onset: Results from a representative US sample of current or former
drinkers</article-title>. <source>Pediatrics</source>
<year>2008</year>;<volume>122</volume>:<fpage>e298</fpage>&#x02013;<lpage>304</lpage>.<pub-id pub-id-type="pmid">18676515</pub-id>
</mixed-citation></ref><ref id="R38"><label>[38]</label><mixed-citation publication-type="journal"><name><surname>Stein</surname><given-names>MD</given-names></name>, <name><surname>Conti</surname><given-names>MT</given-names></name>, <name><surname>Kenney</surname><given-names>S</given-names></name>, <etal/>
<article-title>Adverse childhood experience effects on opioid use initiation,
injection drug use, and overdose among persons with opioid use
disorder</article-title>. <source>Drug Alcohol Depend</source>
<year>2017</year>;<volume>179</volume>:<fpage>325</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">28841495</pub-id>
</mixed-citation></ref><ref id="R39"><label>[39]</label><mixed-citation publication-type="journal"><name><surname>Spencer</surname><given-names>AE</given-names></name>, <name><surname>Valentine</surname><given-names>SE</given-names></name>, <name><surname>Sikov</surname><given-names>J</given-names></name>, <etal/>
<article-title>Principles of care for young adults with co-occurring psychiatric
and substance use disorders</article-title>. <source>Pediatrics</source>
<year>2021</year>;<volume>147</volume>:<fpage>229</fpage>&#x02013;<lpage>39</lpage>.<pub-id pub-id-type="pmid">33386320</pub-id>
</mixed-citation></ref><ref id="R40"><label>[40]</label><mixed-citation publication-type="journal"><name><surname>Grummitt</surname><given-names>LR</given-names></name>, <name><surname>Keyes</surname><given-names>KM</given-names></name>, <name><surname>Rajan</surname><given-names>S</given-names></name>, <etal/>
<article-title>Clusters of adversity types among U.S. youth: Associations with
mental health</article-title>. <source>Am J Prev Med</source>
<year>2022</year>;<volume>63</volume>:<fpage>331</fpage>&#x02013;<lpage>40</lpage>.<pub-id pub-id-type="pmid">35523697</pub-id>
</mixed-citation></ref><ref id="R41"><label>[41]</label><mixed-citation publication-type="journal"><name><surname>Hughes</surname><given-names>K</given-names></name>, <name><surname>Bellis</surname><given-names>MA</given-names></name>, <name><surname>Sethi</surname><given-names>D</given-names></name>, <etal/>
<article-title>Adverse childhood experiences, childhood relationships and
associated substance use and mental health in young
Europeans</article-title>. <source>Eur J Publ Health</source>
<year>2019</year>;<volume>29</volume>:<fpage>741</fpage>&#x02013;<lpage>7</lpage>.</mixed-citation></ref><ref id="R42"><label>[42]</label><mixed-citation publication-type="journal"><name><surname>Lensch</surname><given-names>T</given-names></name>, <name><surname>Clements-Nolle</surname><given-names>K</given-names></name>, <name><surname>Oman</surname><given-names>RF</given-names></name>, <etal/>
<article-title>Adverse childhood experiences and co-occurring psychological
distress and substance abuse among juvenile offenders: The role of
protective factors</article-title>. <source>Publ Health</source>
<year>2021</year>;<volume>194</volume>:<fpage>42</fpage>&#x02013;<lpage>7</lpage>.</mixed-citation></ref><ref id="R43"><label>[43]</label><mixed-citation publication-type="journal"><name><surname>McCabe</surname><given-names>SE</given-names></name>, <name><surname>Hughes</surname><given-names>TL</given-names></name>, <name><surname>West</surname><given-names>BT</given-names></name>, <etal/>
<article-title>Sexual orientation, adverse childhood experiences, and comorbid
DSM-5 substance use and mental health disorders</article-title>. <source>J Clin Psychiatry</source>
<year>2020</year>;<fpage>81</fpage>.</mixed-citation></ref><ref id="R44"><label>[44]</label><mixed-citation publication-type="journal"><name><surname>Swendsen</surname><given-names>J</given-names></name>, <name><surname>Conway</surname><given-names>KP</given-names></name>, <name><surname>Degenhardt</surname><given-names>L</given-names></name>, <etal/>
<article-title>Mental disorders as risk factors for substance use, abuse and
dependence: Results from the 10-year follow-up of the national comorbidity
survey</article-title>. <source>Addiction</source>
<year>2010</year>;<volume>105</volume>:<fpage>1117</fpage>&#x02013;<lpage>28</lpage>.<pub-id pub-id-type="pmid">20331554</pub-id>
</mixed-citation></ref><ref id="R45"><label>[45]</label><mixed-citation publication-type="journal"><name><surname>Srivastava</surname><given-names>AB</given-names></name>, <name><surname>Gold</surname><given-names>MS</given-names></name>. <article-title>Beyond supply: How we must tackle the opioid
epidemic</article-title>. <source>Mayo Clin Proc</source>
<year>2018</year>;<volume>93</volume>:<fpage>269</fpage>&#x02013;<lpage>72</lpage>.<pub-id pub-id-type="pmid">29502558</pub-id>
</mixed-citation></ref><ref id="R46"><label>[46]</label><mixed-citation publication-type="journal"><name><surname>Kosterman</surname><given-names>R</given-names></name>, <name><surname>Mason</surname><given-names>WA</given-names></name>, <name><surname>Haggerty</surname><given-names>KP</given-names></name>, <etal/>
<article-title>Positive childhood experiences and positive adult functioning:
Prosocial continuity and the role of adolescent substance
use</article-title>. <source>J Adol Health</source>
<year>2011</year>;<volume>49</volume>:<fpage>180</fpage>&#x02013;<lpage>6</lpage>.</mixed-citation></ref><ref id="R47"><label>[47]</label><mixed-citation publication-type="journal"><name><surname>Bethell</surname><given-names>C</given-names></name>, <name><surname>Jones</surname><given-names>J</given-names></name>, <name><surname>Gombojav</surname><given-names>N</given-names></name>, <etal/>
<article-title>Positive childhood experiences and adult mental and relational
health in a Statewide sample: Associations across adverse childhood
experiences levels</article-title>. <source>JAMA Pediatr</source>
<year>2019</year>;<volume>173</volume>:<fpage>e193007</fpage>.<pub-id pub-id-type="pmid">31498386</pub-id>
</mixed-citation></ref><ref id="R48"><label>[48]</label><mixed-citation publication-type="book"><name><surname>Fortson</surname><given-names>B</given-names></name>, <name><surname>Klevens</surname><given-names>J</given-names></name>, <name><surname>Merrick</surname><given-names>M</given-names></name>, <etal/>
<part-title>Preventing child abuse and neglect: A technical package for
policy, norm, and programmatic activities</part-title>. In:
<source>Control NCfIPa</source>. <publisher-loc>Atlanta, GA</publisher-loc>:
<publisher-name>Centers for Disease Control and Prevention</publisher-name>;
<year>2016</year>.</mixed-citation></ref><ref id="R49"><label>[49]</label><mixed-citation publication-type="webpage"><collab>Centers for Disease Control and
Prevention</collab>. <source>Adverse childhood experiences</source>.
<comment>Available at</comment>: <comment><ext-link xlink:href="https://www.cdc.gov/violenceprevention/childabuseandneglect/acestudy/index.html" ext-link-type="uri">https://www.cdc.gov/violenceprevention/childabuseandneglect/acestudy/index.html</ext-link></comment>.
<date-in-citation>Accessed May 10, 2019</date-in-citation>.</mixed-citation></ref></ref-list></back><floats-group><fig position="float" id="F1"><label>Figure 1.</label><caption><title>Prevalence of substance use and adjusted associations among U.S. adolescents
exposed to cumulative adverse childhood experiences (ACEs) during the COVID-19
pandemic, Adolescent Behavior and Experiences Survey, January&#x02013;June
2021.</title></caption><graphic xlink:href="nihms-2049072-f0001" position="float"/></fig><table-wrap position="float" id="T1" orientation="landscape"><label>Table 1</label><caption><p id="P36">Individual and relative associations between specific adverse childhood
experiences (ACEs) and substance use among U.S. adolescents during the COVID-19
pandemic, Adolescent Behavior and Experiences Survey, January&#x02014;June
2021</p></caption><table frame="hsides" rules="none"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" valign="top" rowspan="1" colspan="1"/><th colspan="4" align="left" valign="top" rowspan="1">Current alcohol use<hr/></th><th colspan="4" align="left" valign="top" rowspan="1">Current binge drinking<hr/></th><th colspan="4" align="left" valign="top" rowspan="1">Alcohol use increased during
COVID-19<hr/></th><th colspan="4" align="left" valign="top" rowspan="1">Current marijuana use<hr/></th><th colspan="4" align="left" valign="top" rowspan="1">Current prescription pain
medication misuse<hr/></th><th colspan="4" align="left" valign="top" rowspan="1">Drug use increased during
COVID-19<hr/></th></tr><tr><th align="left" valign="top" rowspan="1" colspan="1"/><th align="left" valign="top" rowspan="1" colspan="1">% Yes, 95% CI</th><th align="left" valign="top" rowspan="1" colspan="1">%No, 95% CI</th><th align="left" valign="top" rowspan="1" colspan="1">aPR<sup><xref rid="TFN2" ref-type="table-fn">a</xref></sup></th><th align="left" valign="top" rowspan="1" colspan="1">aPR<sup><xref rid="TFN3" ref-type="table-fn">b</xref></sup></th><th align="left" valign="top" rowspan="1" colspan="1">% Yes, 95% CI</th><th align="left" valign="top" rowspan="1" colspan="1">%No, 95% CI</th><th align="left" valign="top" rowspan="1" colspan="1">aPR<sup><xref rid="TFN2" ref-type="table-fn">a</xref></sup></th><th align="left" valign="top" rowspan="1" colspan="1">aPR<sup><xref rid="TFN3" ref-type="table-fn">b</xref></sup></th><th align="left" valign="top" rowspan="1" colspan="1">% Yes, 95% CI</th><th align="left" valign="top" rowspan="1" colspan="1">%No, 95% CI</th><th align="left" valign="top" rowspan="1" colspan="1">aPR<sup><xref rid="TFN2" ref-type="table-fn">a</xref></sup></th><th align="left" valign="top" rowspan="1" colspan="1">aPR<sup><xref rid="TFN3" ref-type="table-fn">b</xref></sup></th><th align="left" valign="top" rowspan="1" colspan="1">% Yes, 95% CI</th><th align="left" valign="top" rowspan="1" colspan="1">%No, 95% CI</th><th align="left" valign="top" rowspan="1" colspan="1">aPR<sup><xref rid="TFN2" ref-type="table-fn">a</xref></sup></th><th align="left" valign="top" rowspan="1" colspan="1">aPR<sup><xref rid="TFN3" ref-type="table-fn">b</xref></sup></th><th align="left" valign="top" rowspan="1" colspan="1">% Yes, 95% CI</th><th align="left" valign="top" rowspan="1" colspan="1">%No, 95% CI</th><th align="left" valign="top" rowspan="1" colspan="1">aPR<sup><xref rid="TFN2" ref-type="table-fn">a</xref>,<xref rid="TFN4" ref-type="table-fn">c</xref></sup></th><th align="left" valign="top" rowspan="1" colspan="1">aPR<sup><xref rid="TFN3" ref-type="table-fn">b</xref>,<xref rid="TFN4" ref-type="table-fn">c</xref></sup></th><th align="left" valign="top" rowspan="1" colspan="1">% Yes, 95% CI</th><th align="left" valign="top" rowspan="1" colspan="1">%No, 95% CI</th><th align="left" valign="top" rowspan="1" colspan="1">aPR<sup><xref rid="TFN2" ref-type="table-fn">a</xref></sup></th><th align="left" valign="top" rowspan="1" colspan="1">aPR<sup><xref rid="TFN3" ref-type="table-fn">b</xref></sup></th></tr></thead><tbody><tr><td colspan="25" align="left" valign="bottom" rowspan="1">
<hr/>
</td></tr><tr><td colspan="25" align="left" valign="bottom" rowspan="1">Physical abuse during
COVID-19</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Yes (n = 481)</td><td align="left" valign="top" rowspan="1" colspan="1">23.0% (17.8&#x02013;28.2)</td><td align="left" valign="top" rowspan="1" colspan="1">77.0% (71.8&#x02013;82.3)</td><td align="left" valign="top" rowspan="1" colspan="1">1.54 (1.20&#x02013;1.97)</td><td align="left" valign="top" rowspan="1" colspan="1">1.02 (0.77&#x02013;1.35)</td><td align="left" valign="top" rowspan="1" colspan="1">12.1% (7.9&#x02013;16.2)</td><td align="left" valign="top" rowspan="1" colspan="1">87.9% (83.8&#x02013;92.1)</td><td align="left" valign="top" rowspan="1" colspan="1">1.92 (1.36&#x02013;2.71)</td><td align="left" valign="top" rowspan="1" colspan="1">1.24 (0.85&#x02013;1.82)</td><td align="left" valign="top" rowspan="1" colspan="1">21.5% (15.9&#x02013;27.2)</td><td align="left" valign="top" rowspan="1" colspan="1">78.5% (72.8&#x02013;84.1)</td><td align="left" valign="top" rowspan="1" colspan="1">2.09 (1.61&#x02013;2.70)</td><td align="left" valign="top" rowspan="1" colspan="1">1.32 (1.00&#x02013;1.75)</td><td align="left" valign="top" rowspan="1" colspan="1">17.0% (12.6&#x02013;21.3)</td><td align="left" valign="top" rowspan="1" colspan="1">83.0% (78.7&#x02013;87.4)</td><td align="left" valign="top" rowspan="1" colspan="1">1.92 (1.50&#x02013;2.47)</td><td align="left" valign="top" rowspan="1" colspan="1">1.21 (0.92&#x02013;1.60)</td><td align="left" valign="top" rowspan="1" colspan="1">9.1% (6.3&#x02013;11.9)</td><td align="left" valign="top" rowspan="1" colspan="1">90.9% (88.1&#x02013;93.7)</td><td align="left" valign="top" rowspan="1" colspan="1">2.5 (1.64&#x02013;3.81)</td><td align="left" valign="top" rowspan="1" colspan="1">1.57 (1.02&#x02013;2.44)</td><td align="left" valign="top" rowspan="1" colspan="1">16.3% (11.9&#x02013;20.8)</td><td align="left" valign="top" rowspan="1" colspan="1">83.7% (79.2&#x02013;88.1)</td><td align="left" valign="top" rowspan="1" colspan="1">1.93 (1.51&#x02013;2.48)</td><td align="left" valign="top" rowspan="1" colspan="1">1.16 (0.88&#x02013;1.53)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;No (n = 3893)</td><td align="left" valign="top" rowspan="1" colspan="1">15.2% (12.8&#x02013;17.6)</td><td align="left" valign="top" rowspan="1" colspan="1">84.8% (82.4&#x02013;87.2)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">7.2% (5.0&#x02013;9.3)</td><td align="left" valign="top" rowspan="1" colspan="1">92.8% (90.7&#x02013;95.0)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">10.6% (9.3&#x02013;11.9)</td><td align="left" valign="top" rowspan="1" colspan="1">89.4% (88.1&#x02013;90.7)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">9.1% (7.3&#x02013;10.9)</td><td align="left" valign="top" rowspan="1" colspan="1">90.9% (89.1&#x02013;92.7)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">3.3% (2.4&#x02013;4.2)</td><td align="left" valign="top" rowspan="1" colspan="1">96.7% (95.8&#x02013;97.6)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">8.6% (7.1&#x02013;10.0)</td><td align="left" valign="top" rowspan="1" colspan="1">91.4% (90.0&#x02013;92.9)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td colspan="25" align="left" valign="top" rowspan="1">Emotional abuse during
COVID-19</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Yes (n = 2424)</td><td align="left" valign="top" rowspan="1" colspan="1">22.0% (19.3&#x02013;24.7)</td><td align="left" valign="top" rowspan="1" colspan="1">78.0% (75.3&#x02013;80.7)</td><td align="left" valign="top" rowspan="1" colspan="1">2.32 (1.87&#x02013;2.87)</td><td align="left" valign="top" rowspan="1" colspan="1">1.96 (1.54&#x02013;2.49)</td><td align="left" valign="top" rowspan="1" colspan="1">10.6% (7.7&#x02013;13.4)</td><td align="left" valign="top" rowspan="1" colspan="1">89.4% (86.6&#x02013;92.3)</td><td align="left" valign="top" rowspan="1" colspan="1">2.4 (1.78&#x02013;3.24)</td><td align="left" valign="top" rowspan="1" colspan="1">1.84 (1.30&#x02013;2.61)</td><td align="left" valign="top" rowspan="1" colspan="1">16.4% (14.5&#x02013;18.3)</td><td align="left" valign="top" rowspan="1" colspan="1">83.6% (81.7&#x02013;85.5)</td><td align="left" valign="top" rowspan="1" colspan="1">2.68 (2.10&#x02013;3.42)</td><td align="left" valign="top" rowspan="1" colspan="1">2.17 (1.63&#x02013;2.89)</td><td align="left" valign="top" rowspan="1" colspan="1">13.8% (11.2&#x02013;16.4)</td><td align="left" valign="top" rowspan="1" colspan="1">86.2% (83.6&#x02013;88.8)</td><td align="left" valign="top" rowspan="1" colspan="1">2.73 (2.12&#x02013;3.51)</td><td align="left" valign="top" rowspan="1" colspan="1">2.26 (1.66&#x02013;3.07)</td><td align="left" valign="top" rowspan="1" colspan="1">5.8% (4.4&#x02013;7.2)</td><td align="left" valign="top" rowspan="1" colspan="1">94.2% (92.8&#x02013;95.6)</td><td align="left" valign="top" rowspan="1" colspan="1">3.25 (2.00&#x02013;5.27)</td><td align="left" valign="top" rowspan="1" colspan="1">2.54 (1.52&#x02013;4.24)</td><td align="left" valign="top" rowspan="1" colspan="1">13.6% (11.4&#x02013;15.8)</td><td align="left" valign="top" rowspan="1" colspan="1">86.4% (84.2&#x02013;88.6)</td><td align="left" valign="top" rowspan="1" colspan="1">3.17 (2.40&#x02013;4.19)</td><td align="left" valign="top" rowspan="1" colspan="1">2.58 (1.85&#x02013;3.61)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;No (n = 1950)</td><td align="left" valign="top" rowspan="1" colspan="1">8.7% (6.4&#x02013;10.9)</td><td align="left" valign="top" rowspan="1" colspan="1">91.3% (89.1&#x02013;93.6)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">4.1% (2.7&#x02013;5.6)</td><td align="left" valign="top" rowspan="1" colspan="1">95.9% (94.4&#x02013;97.3)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">6.0% (4.5&#x02013;7.5)</td><td align="left" valign="top" rowspan="1" colspan="1">94.0% (02.5&#x02013;95.5)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">5.2% (3.7&#x02013;6.6)</td><td align="left" valign="top" rowspan="1" colspan="1">94.8% (93.4&#x02013;96.3)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">1.6% (0.9&#x02013;2.3)</td><td align="left" valign="top" rowspan="1" colspan="1">98.4% (97.7&#x02013;99.1)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">4.2% (2.9&#x02013;5.4)</td><td align="left" valign="top" rowspan="1" colspan="1">95.8% (94.6&#x02013;97.1)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td colspan="25" align="left" valign="top" rowspan="1">Any sexual violence in the past
12 months</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Yes (n = 424)</td><td align="left" valign="top" rowspan="1" colspan="1">44.7% (39.0&#x02013;50.5)</td><td align="left" valign="top" rowspan="1" colspan="1">55.3% (49.5&#x02013;61.0)</td><td align="left" valign="top" rowspan="1" colspan="1">2.67 (2.16&#x02013;3.29)</td><td align="left" valign="top" rowspan="1" colspan="1">2.02 (1.54&#x02013;2.63)</td><td align="left" valign="top" rowspan="1" colspan="1">26.6% (20.2&#x02013;33.0)</td><td align="left" valign="top" rowspan="1" colspan="1">73.4% (67.0&#x02013;79.8)</td><td align="left" valign="top" rowspan="1" colspan="1">3.59 (2.58&#x02013;4.99)</td><td align="left" valign="top" rowspan="1" colspan="1">2.58 (1.76&#x02013;3.70)</td><td align="left" valign="top" rowspan="1" colspan="1">29.3% (23.5&#x02013;35.1)</td><td align="left" valign="top" rowspan="1" colspan="1">70.7% (64.9&#x02013;76.5)</td><td align="left" valign="top" rowspan="1" colspan="1">2.72 (2.13&#x02013;3.47)</td><td align="left" valign="top" rowspan="1" colspan="1">1.92 (1.36&#x02013;2.72)</td><td align="left" valign="top" rowspan="1" colspan="1">30.5% (23.8&#x02013;37.3)</td><td align="left" valign="top" rowspan="1" colspan="1">69.5% (62.7&#x02013;76.2)</td><td align="left" valign="top" rowspan="1" colspan="1">3.5 (2.79&#x02013;4.38)</td><td align="left" valign="top" rowspan="1" colspan="1">2.68 (2.11&#x02013;3.41)</td><td align="left" valign="top" rowspan="1" colspan="1">9.7% (6.6&#x02013;12.8)</td><td align="left" valign="top" rowspan="1" colspan="1">90.3% (87.2&#x02013;93.4)</td><td align="left" valign="top" rowspan="1" colspan="1">2.26 (1.60&#x02013;3.18)</td><td align="left" valign="top" rowspan="1" colspan="1">1.41 (0.93&#x02013;2.12)</td><td align="left" valign="top" rowspan="1" colspan="1">30.1% (24.7&#x02013;35.6)</td><td align="left" valign="top" rowspan="1" colspan="1">69.9% (64.4&#x02013;75.3)</td><td align="left" valign="top" rowspan="1" colspan="1">3.63 (2.86&#x02013;4.59)</td><td align="left" valign="top" rowspan="1" colspan="1">2.67 (2.02&#x02013;3.54)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;No (n = 3950)</td><td align="left" valign="top" rowspan="1" colspan="1">13.1% (11.1&#x02013;15.1)</td><td align="left" valign="top" rowspan="1" colspan="1">86.9% (84.9&#x02013;88.9)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">5.8% (4.0&#x02013;7.5)</td><td align="left" valign="top" rowspan="1" colspan="1">94.2% (92.5&#x02013;96.0)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">9.9% (8.6&#x02013;11.2)</td><td align="left" valign="top" rowspan="1" colspan="1">90.1% (88.8&#x02013;91.4)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">7.8% (6.5&#x02013;9.2)</td><td align="left" valign="top" rowspan="1" colspan="1">92.2% (90.8&#x02013;93.5)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">3.3% (2.6&#x02013;4.1)</td><td align="left" valign="top" rowspan="1" colspan="1">96.7% (95.9&#x02013;97.4)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">7.3% (6.1&#x02013;8.4)</td><td align="left" valign="top" rowspan="1" colspan="1">92.7% (91.6&#x02013;93.9)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td colspan="25" align="left" valign="top" rowspan="1">Physical dating violence in the
past 12 months</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Yes (n = 128)</td><td align="left" valign="top" rowspan="1" colspan="1">47.6% (35.8&#x02013;59.4)</td><td align="left" valign="top" rowspan="1" colspan="1">52.4% (40.6&#x02013;64.2)</td><td align="left" valign="top" rowspan="1" colspan="1">2.42 (1.76&#x02013;3.32)</td><td align="left" valign="top" rowspan="1" colspan="1">1.39 (0.96&#x02013;2.02)</td><td align="left" valign="top" rowspan="1" colspan="1">29.6% (20.4&#x02013;38.8)</td><td align="left" valign="top" rowspan="1" colspan="1">70.4% (61.2&#x02013;79.6)</td><td align="left" valign="top" rowspan="1" colspan="1">3.04 (1.86&#x02013;4.97)</td><td align="left" valign="top" rowspan="1" colspan="1">1.56 (0.93&#x02013;2.61)</td><td align="left" valign="top" rowspan="1" colspan="1">36.2% (23.6&#x02013;48.8)</td><td align="left" valign="top" rowspan="1" colspan="1">63.8% (51.2&#x02013;76.4)</td><td align="left" valign="top" rowspan="1" colspan="1">2.83 (1.89&#x02013;4.26)</td><td align="left" valign="top" rowspan="1" colspan="1">1.55 (0.92&#x02013;2.62)</td><td align="left" valign="top" rowspan="1" colspan="1">32.7% (23.3&#x02013;42.2)</td><td align="left" valign="top" rowspan="1" colspan="1">67.3% (57.8&#x02013;76.7)</td><td align="left" valign="top" rowspan="1" colspan="1">2.82 (1.79&#x02013;4.46)</td><td align="left" valign="top" rowspan="1" colspan="1">1.45 (0.88&#x02013;2.39)</td><td align="left" valign="top" rowspan="1" colspan="1">15.2% (7.4&#x02013;22.9)</td><td align="left" valign="top" rowspan="1" colspan="1">84.8% (77.1&#x02013;92.6)</td><td align="left" valign="top" rowspan="1" colspan="1">3.32 (1.92&#x02013;5.76)</td><td align="left" valign="top" rowspan="1" colspan="1">1.99 (0.89&#x02013;4.47)</td><td align="left" valign="top" rowspan="1" colspan="1">29.6% (19.7&#x02013;39.5)</td><td align="left" valign="top" rowspan="1" colspan="1">70.4% (60.5&#x02013;80.3)</td><td align="left" valign="top" rowspan="1" colspan="1">2.69 (1.70&#x02013;4.26)</td><td align="left" valign="top" rowspan="1" colspan="1">1.27 (0.78&#x02013;2.08)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;No (n = 4246)</td><td align="left" valign="top" rowspan="1" colspan="1">15.1% (12.9&#x02013;17.3)</td><td align="left" valign="top" rowspan="1" colspan="1">84.9% (82.7&#x02013;87.1)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">7.1% (5.0&#x02013;9.2)</td><td align="left" valign="top" rowspan="1" colspan="1">92.9% (90.8&#x02013;95.0)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">11.0% (9.7&#x02013;12.4)</td><td align="left" valign="top" rowspan="1" colspan="1">89.0% (87.6&#x02013;90.3)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">9.3% (7.5&#x02013;11.2)</td><td align="left" valign="top" rowspan="1" colspan="1">90.7% (88.8&#x02013;92.5)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">3.6% (2.8&#x02013;4.4)</td><td align="left" valign="top" rowspan="1" colspan="1">96.4% (95.6&#x02013;97.2)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">8.8% (7.3&#x02013;10.3)</td><td align="left" valign="top" rowspan="1" colspan="1">91.2% (89.7&#x02013;92.7)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td colspan="25" align="left" valign="top" rowspan="1">Cyberbullying in the past 12
Mmonths</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Yes (n = 569)</td><td align="left" valign="top" rowspan="1" colspan="1">26.8% (21.9&#x02013;31.6)</td><td align="left" valign="top" rowspan="1" colspan="1">73.2% (68.4&#x02013;78.1)</td><td align="left" valign="top" rowspan="1" colspan="1">1.66 (1.41&#x02013;1.95)</td><td align="left" valign="top" rowspan="1" colspan="1">1.12 (0.93&#x02013;1.34)</td><td align="left" valign="top" rowspan="1" colspan="1">15.1% (10.3&#x02013;19.9)</td><td align="left" valign="top" rowspan="1" colspan="1">84.9% (80.1&#x02013;89.7)</td><td align="left" valign="top" rowspan="1" colspan="1">2.08 (1.63&#x02013;2.66)</td><td align="left" valign="top" rowspan="1" colspan="1">1.28 (0.97&#x02013;1.68)</td><td align="left" valign="top" rowspan="1" colspan="1">18.0% (13.6&#x02013;22.4)</td><td align="left" valign="top" rowspan="1" colspan="1">82.0% (77.6&#x02013;86.4)</td><td align="left" valign="top" rowspan="1" colspan="1">1.6 (1.22&#x02013;2.09)</td><td align="left" valign="top" rowspan="1" colspan="1">1.00 (0.74&#x02013;1.33)</td><td align="left" valign="top" rowspan="1" colspan="1">15.6% (10.9&#x02013;20.2)</td><td align="left" valign="top" rowspan="1" colspan="1">84.4% (79.8&#x02013;89.1)</td><td align="left" valign="top" rowspan="1" colspan="1">1.66 (1.28&#x02013;2.16)</td><td align="left" valign="top" rowspan="1" colspan="1">1.00 (0.73&#x02013;1.35)</td><td align="left" valign="top" rowspan="1" colspan="1">6.2% (2.8&#x02013;9.7)</td><td align="left" valign="top" rowspan="1" colspan="1">93.8% (90.3&#x02013;97.2)</td><td align="left" valign="top" rowspan="1" colspan="1">1.56 (0.85&#x02013;2.86)</td><td align="left" valign="top" rowspan="1" colspan="1">0.95 (0.46&#x02013;1.95)</td><td align="left" valign="top" rowspan="1" colspan="1">16.7% (12.3&#x02013;21.1)</td><td align="left" valign="top" rowspan="1" colspan="1">83.3% (78.9&#x02013;87.7)</td><td align="left" valign="top" rowspan="1" colspan="1">1.87 (1.45&#x02013;2.40)</td><td align="left" valign="top" rowspan="1" colspan="1">1.11 (0.82&#x02013;1.51)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;No (n = 3805)</td><td align="left" valign="top" rowspan="1" colspan="1">14.4% (12.3&#x02013;16.5)</td><td align="left" valign="top" rowspan="1" colspan="1">85.6% (83.5&#x02013;87.7)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">6.6% (4.8&#x02013;8.4)</td><td align="left" valign="top" rowspan="1" colspan="1">93.4% (91.6&#x02013;95.2)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">10.8% (9.3&#x02013;12.3)</td><td align="left" valign="top" rowspan="1" colspan="1">89.2% (87.7&#x02013;90.7)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">9.1% (7.4&#x02013;10.8)</td><td align="left" valign="top" rowspan="1" colspan="1">90.9% (89.2&#x02013;92.6)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">3.6% (2.7&#x02013;4.5)</td><td align="left" valign="top" rowspan="1" colspan="1">96.4% (95.5&#x02013;97.3)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">8.3% (6.9&#x02013;9.6)</td><td align="left" valign="top" rowspan="1" colspan="1">91.7% (90.4&#x02013;93.1)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td colspan="25" align="left" valign="top" rowspan="1">Parent lost job during
COVID-19</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Yes (n = 1195)</td><td align="left" valign="top" rowspan="1" colspan="1">20.2% (16.6&#x02013;23.9)</td><td align="left" valign="top" rowspan="1" colspan="1">79.8% (76.1&#x02013;83.4)</td><td align="left" valign="top" rowspan="1" colspan="1">1.45 (1.25&#x02013;1.69)</td><td align="left" valign="top" rowspan="1" colspan="1">1.33 (1.15&#x02013;1.54)</td><td align="left" valign="top" rowspan="1" colspan="1">10.1% (7.1&#x02013;13.0)</td><td align="left" valign="top" rowspan="1" colspan="1">89.9% (87.0&#x02013;92.9)</td><td align="left" valign="top" rowspan="1" colspan="1">1.59 (1.22&#x02013;2.08)</td><td align="left" valign="top" rowspan="1" colspan="1">1.44 (1.13&#x02013;1.83)</td><td align="left" valign="top" rowspan="1" colspan="1">13.9% (11.2&#x02013;16.6)</td><td align="left" valign="top" rowspan="1" colspan="1">86.1% (83.4&#x02013;88.8)</td><td align="left" valign="top" rowspan="1" colspan="1">1.35 (1.09&#x02013;1.66)</td><td align="left" valign="top" rowspan="1" colspan="1">1.19 (0.95&#x02013;1.49)</td><td align="left" valign="top" rowspan="1" colspan="1">12.5% (9.8&#x02013;15.3)</td><td align="left" valign="top" rowspan="1" colspan="1">87.5% (84.7&#x02013;90.2)</td><td align="left" valign="top" rowspan="1" colspan="1">1.48 (1.28&#x02013;1.71)</td><td align="left" valign="top" rowspan="1" colspan="1">1.36 (1.15&#x02013;1.61)</td><td align="left" valign="top" rowspan="1" colspan="1">4.8% (3.2&#x02013;6.4)</td><td align="left" valign="top" rowspan="1" colspan="1">95.2% (93.6&#x02013;96.8)</td><td align="left" valign="top" rowspan="1" colspan="1">1.29 (0.88&#x02013;1.88)</td><td align="left" valign="top" rowspan="1" colspan="1">1.08 (0.74&#x02013;1.58)</td><td align="left" valign="top" rowspan="1" colspan="1">10.7% (7.9&#x02013;13.6)</td><td align="left" valign="top" rowspan="1" colspan="1">89.3% (86.4&#x02013;92.1)</td><td align="left" valign="top" rowspan="1" colspan="1">1.29 (0.97&#x02013;1.70)</td><td align="left" valign="top" rowspan="1" colspan="1">1.15 (0.86&#x02013;1.54)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;No (n = 3179)</td><td align="left" valign="top" rowspan="1" colspan="1">14.3% (12.0&#x02013;16.5)</td><td align="left" valign="top" rowspan="1" colspan="1">85.7% (83.5&#x02013;88.0)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">6.7% (4.6&#x02013;8.8)</td><td align="left" valign="top" rowspan="1" colspan="1">93.3% (91.2&#x02013;95.4)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">10.8% (9.3&#x02013;12.3)</td><td align="left" valign="top" rowspan="1" colspan="1">89.2% (87.7&#x02013;90.7)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">8.9% (7.2&#x02013;10.6)</td><td align="left" valign="top" rowspan="1" colspan="1">91.1% (89.4&#x02013;92.8)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">3.5% (2.6&#x02013;4.5)</td><td align="left" valign="top" rowspan="1" colspan="1">96.5% (95.5&#x02013;97.4)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">8.8% (7.2&#x02013;10.4)</td><td align="left" valign="top" rowspan="1" colspan="1">91.2% (89.6&#x02013;92.8)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td colspan="25" align="left" valign="top" rowspan="1">Food Insecurity during
COVID-19</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Yes (n = 942)</td><td align="left" valign="top" rowspan="1" colspan="1">20.2% (15.7&#x02013;24.8)</td><td align="left" valign="top" rowspan="1" colspan="1">79.8% (75.2&#x02013;84.3)</td><td align="left" valign="top" rowspan="1" colspan="1">1.48 (1.17&#x02013;1.86)</td><td align="left" valign="top" rowspan="1" colspan="1">1.08 (0.85&#x02013;1.37)</td><td align="left" valign="top" rowspan="1" colspan="1">8.6% (5.7&#x02013;11.5)</td><td align="left" valign="top" rowspan="1" colspan="1">91.4% (88.5&#x02013;94.3)</td><td align="left" valign="top" rowspan="1" colspan="1">1.36 (0.99&#x02013;1.87)</td><td align="left" valign="top" rowspan="1" colspan="1">0.88 (0.65&#x02013;1.20)</td><td align="left" valign="top" rowspan="1" colspan="1">17.0% (13.3&#x02013;20.7)</td><td align="left" valign="top" rowspan="1" colspan="1">83.0% (79.3&#x02013;86.7)</td><td align="left" valign="top" rowspan="1" colspan="1">1.81 (1.41&#x02013;2.32)</td><td align="left" valign="top" rowspan="1" colspan="1">1.31 (1.02&#x02013;1.67)</td><td align="left" valign="top" rowspan="1" colspan="1">12.2% (8.8&#x02013;15.6)</td><td align="left" valign="top" rowspan="1" colspan="1">87.8% (84.4&#x02013;91.2)</td><td align="left" valign="top" rowspan="1" colspan="1">1.33 (0.98&#x02013;1.80)</td><td align="left" valign="top" rowspan="1" colspan="1">0.91 (0.67&#x02013;1.22)</td><td align="left" valign="top" rowspan="1" colspan="1">6.5% (4.4&#x02013;8.7)</td><td align="left" valign="top" rowspan="1" colspan="1">93.5% (91.3&#x02013;95.6)</td><td align="left" valign="top" rowspan="1" colspan="1">1.97 (1.37&#x02013;2.84)</td><td align="left" valign="top" rowspan="1" colspan="1">1.39 (0.94&#x02013;2.04)</td><td align="left" valign="top" rowspan="1" colspan="1">12.9% (9.7&#x02013;16.0)</td><td align="left" valign="top" rowspan="1" colspan="1">87.1% (84.0&#x02013;90.3)</td><td align="left" valign="top" rowspan="1" colspan="1">1.57 (1.24&#x02013;2.00)</td><td align="left" valign="top" rowspan="1" colspan="1">1.09 (0.85&#x02013;1.39)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;No (n = 3432)</td><td align="left" valign="top" rowspan="1" colspan="1">14.8% (12.2&#x02013;17.4)</td><td align="left" valign="top" rowspan="1" colspan="1">85.2% (82.6&#x02013;87.8)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">7.4% (5.1&#x02013;9.8)</td><td align="left" valign="top" rowspan="1" colspan="1">92.6% (90.2&#x02013;94.9)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">10.2% (8.7&#x02013;11.7)</td><td align="left" valign="top" rowspan="1" colspan="1">89.8% (88.3&#x02013;91.3)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">9.3% (7.4&#x02013;11.2)</td><td align="left" valign="top" rowspan="1" colspan="1">90.7% (88.8&#x02013;92.6)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">3.2% (2.4&#x02013;3.9)</td><td align="left" valign="top" rowspan="1" colspan="1">96.8% (96.1&#x02013;97.6)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">8.4% (6.8&#x02013;10.0)</td><td align="left" valign="top" rowspan="1" colspan="1">91.6% (90.0&#x02013;93.2)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn id="TFN1"><p id="P37">ACEs = adverse childhood experiences; aPR = adjusted prevalence
ratio; CI = confidence interval.</p></fn><fn id="TFN2"><label>a</label><p id="P38">Adjusted for sex, race/ethnicity, age, sexual identity, and method
of school instruction.</p></fn><fn id="TFN3"><label>b</label><p id="P39">Adjusted for sex, race/ethnicity, age, sexual identity, method of
school instruction, and all other individual ACEs.</p></fn><fn id="TFN4"><label>c</label><p id="P40">To ensure model convergence due to small sample sizes, the racial
and ethnic categories were recoded to minimize small sample sizes for some
groups. The racial and ethnic variable coding for these analyses adjusted
specifically for differences for non-Hispanic Black, Hispanic, non-Hispanic
Multiracial, non-Hispanic White, and another race/ethnicity.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="T2" orientation="landscape"><label>Table 2</label><caption><p id="P41">Adjusted associations between thematic adverse childhood experience
(ACE) category exposure and substance use among U.S. adolescents during the
COVID-19 pandemic, Adolescent Behavior and Experiences Survey,
January&#x02014;June 2021</p></caption><table frame="hsides" rules="none"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" valign="top" rowspan="1" colspan="1"/><th colspan="4" align="left" valign="top" rowspan="1">Current alcohol use<hr/></th><th colspan="4" align="left" valign="top" rowspan="1">Current binge drinking<hr/></th><th colspan="4" align="left" valign="top" rowspan="1">Alcohol use increased during
COVID-19<hr/></th><th colspan="4" align="left" valign="top" rowspan="1">Current marijuana use<hr/></th><th colspan="4" align="left" valign="top" rowspan="1">Current prescription pain
medication misuse<hr/></th><th colspan="4" align="left" valign="top" rowspan="1">Drug use increased during
COVID-19<hr/></th></tr><tr><th align="left" valign="top" rowspan="1" colspan="1"/><th align="left" valign="top" rowspan="1" colspan="1">% Yes, 95% CI</th><th align="left" valign="top" rowspan="1" colspan="1">%No, 95% CI</th><th align="left" valign="top" rowspan="1" colspan="1">aPR<sup><xref rid="TFN6" ref-type="table-fn">a</xref></sup></th><th align="left" valign="top" rowspan="1" colspan="1">aPR<sup><xref rid="TFN7" ref-type="table-fn">b</xref></sup></th><th align="left" valign="top" rowspan="1" colspan="1">% Yes, 95% CI</th><th align="left" valign="top" rowspan="1" colspan="1">%No, 95% CI</th><th align="left" valign="top" rowspan="1" colspan="1">aPR<sup><xref rid="TFN6" ref-type="table-fn">a</xref></sup></th><th align="left" valign="top" rowspan="1" colspan="1">aPR<sup><xref rid="TFN7" ref-type="table-fn">b</xref></sup></th><th align="left" valign="top" rowspan="1" colspan="1">% Yes, 95% CI</th><th align="left" valign="top" rowspan="1" colspan="1">%No, 95% CI</th><th align="left" valign="top" rowspan="1" colspan="1">aPR<sup><xref rid="TFN6" ref-type="table-fn">a</xref></sup></th><th align="left" valign="top" rowspan="1" colspan="1">aPR<sup><xref rid="TFN7" ref-type="table-fn">b</xref></sup></th><th align="left" valign="top" rowspan="1" colspan="1">% Yes, 95% CI</th><th align="left" valign="top" rowspan="1" colspan="1">%No, 95% CI</th><th align="left" valign="top" rowspan="1" colspan="1">aPR<sup><xref rid="TFN6" ref-type="table-fn">a</xref></sup></th><th align="left" valign="top" rowspan="1" colspan="1">aPR<sup><xref rid="TFN7" ref-type="table-fn">b</xref></sup></th><th align="left" valign="top" rowspan="1" colspan="1">% Yes, 95% CI</th><th align="left" valign="top" rowspan="1" colspan="1">%No, 95% CI</th><th align="left" valign="top" rowspan="1" colspan="1">aPR<sup><xref rid="TFN6" ref-type="table-fn">a</xref>,<xref rid="TFN8" ref-type="table-fn">c</xref></sup></th><th align="left" valign="top" rowspan="1" colspan="1">aPR<sup><xref rid="TFN7" ref-type="table-fn">b</xref>,<xref rid="TFN8" ref-type="table-fn">c</xref></sup></th><th align="left" valign="top" rowspan="1" colspan="1">% Yes, 95% CI</th><th align="left" valign="top" rowspan="1" colspan="1">%No, 95% CI</th><th align="left" valign="top" rowspan="1" colspan="1">aPR<sup><xref rid="TFN6" ref-type="table-fn">a</xref></sup></th><th align="left" valign="top" rowspan="1" colspan="1">aPR<sup><xref rid="TFN7" ref-type="table-fn">b</xref></sup></th></tr></thead><tbody><tr><td colspan="25" align="left" valign="bottom" rowspan="1">
<hr/>
</td></tr><tr><td colspan="25" align="left" valign="top" rowspan="1">Experiencing abuse by a
parent<sup><xref rid="TFN9" ref-type="table-fn">d</xref></sup></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Yes (n = 2440)</td><td align="left" valign="top" rowspan="1" colspan="1">21.8% (19.1&#x02013;24.5)</td><td align="left" valign="top" rowspan="1" colspan="1">78.2% (75.5&#x02013;80.9)</td><td align="left" valign="top" rowspan="1" colspan="1">2.3 (1.86&#x02013;2.85)</td><td align="left" valign="top" rowspan="1" colspan="1">1.93 (1.53&#x02013;2.43)</td><td align="left" valign="top" rowspan="1" colspan="1">10.5% (7.7&#x02013;13.3)</td><td align="left" valign="top" rowspan="1" colspan="1">89.5% (86.7&#x02013;92.3)</td><td align="left" valign="top" rowspan="1" colspan="1">2.4 (1.78&#x02013;3.24)</td><td align="left" valign="top" rowspan="1" colspan="1">1.88 (1.37&#x02013;2.59)</td><td align="left" valign="top" rowspan="1" colspan="1">16.4% (14.4&#x02013;18.4)</td><td align="left" valign="top" rowspan="1" colspan="1">83.6% (81.6&#x02013;85.6)</td><td align="left" valign="top" rowspan="1" colspan="1">2.78 (2.14&#x02013;3.62)</td><td align="left" valign="top" rowspan="1" colspan="1">2.34 (1.75&#x02013;3.16)</td><td align="left" valign="top" rowspan="1" colspan="1">13.8% (11.2&#x02013;16.4)</td><td align="left" valign="top" rowspan="1" colspan="1">86.2% (83.6&#x02013;88.8)</td><td align="left" valign="top" rowspan="1" colspan="1">2.72 (2.12&#x02013;3.49)</td><td align="left" valign="top" rowspan="1" colspan="1">2.22 (1.69&#x02013;2.93)</td><td align="left" valign="top" rowspan="1" colspan="1">5.8% (4.4&#x02013;7.2)</td><td align="left" valign="top" rowspan="1" colspan="1">94.2% (92.8&#x02013;95.6)</td><td align="left" valign="top" rowspan="1" colspan="1">3.2 (1.97&#x02013;5.20)</td><td align="left" valign="top" rowspan="1" colspan="1">2.73 (1.62&#x02013;4.58)</td><td align="left" valign="top" rowspan="1" colspan="1">13.5% (11.4&#x02013;15.7)</td><td align="left" valign="top" rowspan="1" colspan="1">86.5% (84.3&#x02013;88.6)</td><td align="left" valign="top" rowspan="1" colspan="1">3.15 (2.39&#x02013;4.16)</td><td align="left" valign="top" rowspan="1" colspan="1">2.58 (1.89&#x02013;3.53)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;No (n = 1934)</td><td align="left" valign="top" rowspan="1" colspan="1">8.7% (6.5&#x02013;11.0)</td><td align="left" valign="top" rowspan="1" colspan="1">91.3% (89.0&#x02013;93.5)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">4.1% (2.7&#x02013;5.6)</td><td align="left" valign="top" rowspan="1" colspan="1">95.7% (94.4&#x02013;97.3)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">5.8% (4.3&#x02013;7.3)</td><td align="left" valign="top" rowspan="1" colspan="1">94.2% (92.7&#x02013;95.7)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">5.2% (3.7&#x02013;6.6)</td><td align="left" valign="top" rowspan="1" colspan="1">94.8% (93.4&#x02013;96.3)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">1.6% (0.9&#x02013;2.3)</td><td align="left" valign="top" rowspan="1" colspan="1">98.4% (97.7&#x02013;99.1)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">4.2% (2.9&#x02013;5.4)</td><td align="left" valign="top" rowspan="1" colspan="1">95.8% (94.6&#x02013;97.1)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td colspan="25" align="left" valign="top" rowspan="1">Experiencing other
violence<sup><xref rid="TFN10" ref-type="table-fn">e</xref></sup></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Yes (n = 878)</td><td align="left" valign="top" rowspan="1" colspan="1">31.9% (27.5&#x02013;36.4)</td><td align="left" valign="top" rowspan="1" colspan="1">68.1% (63.6&#x02013;72.5)</td><td align="left" valign="top" rowspan="1" colspan="1">2.26 (1.93&#x02013;2.66)</td><td align="left" valign="top" rowspan="1" colspan="1">1.88 (1.59&#x02013;2.23)</td><td align="left" valign="top" rowspan="1" colspan="1">17.9% (13.4&#x02013;22.5)</td><td align="left" valign="top" rowspan="1" colspan="1">82.1% (77.5&#x02013;86.6)</td><td align="left" valign="top" rowspan="1" colspan="1">2.9 (2.23&#x02013;3.77)</td><td align="left" valign="top" rowspan="1" colspan="1">2.42 (1.82&#x02013;3.20)</td><td align="left" valign="top" rowspan="1" colspan="1">22.0% (18.5&#x02013;25.5)</td><td align="left" valign="top" rowspan="1" colspan="1">78.0% (74.5&#x02013;81.5)</td><td align="left" valign="top" rowspan="1" colspan="1">2.3 (1.82&#x02013;2.90)</td><td align="left" valign="top" rowspan="1" colspan="1">1.83 (1.43&#x02013;2.33)</td><td align="left" valign="top" rowspan="1" colspan="1">21.0% (16.6&#x02013;25.4)</td><td align="left" valign="top" rowspan="1" colspan="1">79.0% (74.6&#x02013;83.4)</td><td align="left" valign="top" rowspan="1" colspan="1">2.74 (2.23&#x02013;3.37)</td><td align="left" valign="top" rowspan="1" colspan="1">2.23 (1.79&#x02013;2.77)</td><td align="left" valign="top" rowspan="1" colspan="1">7.3% (4.6&#x02013;9.9)</td><td align="left" valign="top" rowspan="1" colspan="1">92.7% (90.1&#x02013;95.4)</td><td align="left" valign="top" rowspan="1" colspan="1">1.98 (1.37&#x02013;2.88)</td><td align="left" valign="top" rowspan="1" colspan="1">1.53 (1.07&#x02013;2.20)</td><td align="left" valign="top" rowspan="1" colspan="1">20.2% (16.8&#x02013;23.7)</td><td align="left" valign="top" rowspan="1" colspan="1">79.8% (76.3&#x02013;83.2)</td><td align="left" valign="top" rowspan="1" colspan="1">2.74 (2.18&#x02013;3.44)</td><td align="left" valign="top" rowspan="1" colspan="1">2.17 (1.71&#x02013;2.75)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;No (n = 3496)</td><td align="left" valign="top" rowspan="1" colspan="1">12.2% (10.3&#x02013;14.1)</td><td align="left" valign="top" rowspan="1" colspan="1">87.8% (85.9&#x02013;89.7)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">5.2% (3.6&#x02013;6.9)</td><td align="left" valign="top" rowspan="1" colspan="1">94.8% (93.1&#x02013;96.4)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">9.3% (7.8&#x02013;10.7)</td><td align="left" valign="top" rowspan="1" colspan="1">90.7% (89.3&#x02013;92.2)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">7.3% (5.9&#x02013;8.7)</td><td align="left" valign="top" rowspan="1" colspan="1">92.7% (91.3&#x02013;94.1)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">3.1% (2.4&#x02013;3.8)</td><td align="left" valign="top" rowspan="1" colspan="1">96.9% (96.2&#x02013;97.6)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">6.8% (5.6&#x02013;8.0)</td><td align="left" valign="top" rowspan="1" colspan="1">93.2% (92.0&#x02013;94.4)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td colspan="25" align="left" valign="top" rowspan="1">Family economic
challenges<sup><xref rid="TFN11" ref-type="table-fn">f</xref></sup></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Yes (n = 1766)</td><td align="left" valign="top" rowspan="1" colspan="1">19.2% (15.9&#x02013;22.4)</td><td align="left" valign="top" rowspan="1" colspan="1">80.8% (77.6&#x02013;84.1)</td><td align="left" valign="top" rowspan="1" colspan="1">1.46 (1.24&#x02013;1.73)</td><td align="left" valign="top" rowspan="1" colspan="1">1.24 (1.06&#x02013;1.46)</td><td align="left" valign="top" rowspan="1" colspan="1">9.1% (6.5&#x02013;11.8)</td><td align="left" valign="top" rowspan="1" colspan="1">90.9% (88.2&#x02013;93.5)</td><td align="left" valign="top" rowspan="1" colspan="1">1.52 (1.21&#x02013;1.91)</td><td align="left" valign="top" rowspan="1" colspan="1">1.24 (0.98&#x02013;1.57)</td><td align="left" valign="top" rowspan="1" colspan="1">14.5% (12.1&#x02013;16.9)</td><td align="left" valign="top" rowspan="1" colspan="1">85.5% (83.1&#x02013;87.9)</td><td align="left" valign="top" rowspan="1" colspan="1">1.59 (1.30&#x02013;1.94)</td><td align="left" valign="top" rowspan="1" colspan="1">1.32 (1.07&#x02013;1.64)</td><td align="left" valign="top" rowspan="1" colspan="1">12.2% (9.7&#x02013;14.7)</td><td align="left" valign="top" rowspan="1" colspan="1">87.8% (85.3&#x02013;90.3)</td><td align="left" valign="top" rowspan="1" colspan="1">1.5 (1.28&#x02013;1.75)</td><td align="left" valign="top" rowspan="1" colspan="1">1.22 (1.04&#x02013;1.44)</td><td align="left" valign="top" rowspan="1" colspan="1">5.4% (3.7&#x02013;7.0)</td><td align="left" valign="top" rowspan="1" colspan="1">94.6% (93.0&#x02013;96.3)</td><td align="left" valign="top" rowspan="1" colspan="1">1.79 (1.21&#x02013;2.65)</td><td align="left" valign="top" rowspan="1" colspan="1">1.47 (0.98&#x02013;2.21)</td><td align="left" valign="top" rowspan="1" colspan="1">11.5% (9.3&#x02013;13.7)</td><td align="left" valign="top" rowspan="1" colspan="1">88.5% (86.3&#x02013;90.7)</td><td align="left" valign="top" rowspan="1" colspan="1">1.52 (1.22&#x02013;1.91)</td><td align="left" valign="top" rowspan="1" colspan="1">1.24 (0.97&#x02013;1.57)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;No (n = 2608)</td><td align="left" valign="top" rowspan="1" colspan="1">13.7% (11.3&#x02013;16.1)</td><td align="left" valign="top" rowspan="1" colspan="1">86.3% (83.9&#x02013;88.7)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">6.6% (4.5&#x02013;8.7)</td><td align="left" valign="top" rowspan="1" colspan="1">93.4% (91.3&#x02013;95.5)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">9.7% (8.2&#x02013;11.2)</td><td align="left" valign="top" rowspan="1" colspan="1">90.3% (88.8&#x02013;91.8)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">8.3% (6.7&#x02013;10.0)</td><td align="left" valign="top" rowspan="1" colspan="1">91.7% (90.0&#x02013;93.3)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">2.9% (2.1&#x02013;3.6)</td><td align="left" valign="top" rowspan="1" colspan="1">97.1% (96.4&#x02013;97.9)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">7.9% (6.2&#x02013;9.5)</td><td align="left" valign="top" rowspan="1" colspan="1">92.1% (90.5&#x02013;93.8)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn id="TFN5"><p id="P42">ACEs = adverse childhood experiences; aPR = adjusted prevalence
ratio; CI = confidence interval.</p></fn><fn id="TFN6"><label>a</label><p id="P43">Adjusted for sex, race or ethnicity, age, sexual identity, and
method of school instruction.</p></fn><fn id="TFN7"><label>b</label><p id="P44">Adjusted for sex, race or ethnicity, age, sexual identity, method of
school instruction, and other ACEs categories.</p></fn><fn id="TFN8"><label>c</label><p id="P45">To ensure model convergence due to small sample sizes, the racial
and ethnic categories were recoded to minimize small sample sizes for some
groups. The racial and ethnic variable coding for these analyses adjusted
specifically for differences for non-Hispanic Black, Hispanic, non-Hispanic
Multiracial, non-Hispanic White, and another race/ethnicity.</p></fn><fn id="TFN9"><label>d</label><p id="P46">Category includes physical abuse by a parent, emotional abuse by a
parent.</p></fn><fn id="TFN10"><label>e</label><p id="P47">Category includes any sexual violence, physical dating violence,
cyberbullying.</p></fn><fn id="TFN11"><label>f</label><p id="P48">Category includes parent lost job, food insecurity.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="T3" orientation="landscape"><label>Table 3</label><caption><p id="P49">Mean number of recent adverse childhood experiences (ACEs) during the
COVID-19 pandemic reported by adolescents and substance use, among adolescents
with and without poor mental health, Adolescent Behavior and Experiences Survey,
January&#x02014;June 2021</p></caption><table frame="hsides" rules="none"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" valign="top" rowspan="1" colspan="1"/><th colspan="2" align="left" valign="top" rowspan="1">Current alcohol use<hr/></th><th colspan="2" align="left" valign="top" rowspan="1">Current binge drinking<hr/></th><th colspan="2" align="left" valign="top" rowspan="1">Alcohol use increased during
COVID-19<hr/></th><th colspan="2" align="left" valign="top" rowspan="1">Current marijuana use<hr/></th><th colspan="2" align="left" valign="top" rowspan="1">Current prescription Pain
medication misuse<hr/></th><th colspan="2" align="left" valign="top" rowspan="1">Drug use increased during
COVID-19<hr/></th></tr><tr><th align="left" valign="top" rowspan="1" colspan="1">ACE Count</th><th align="left" valign="top" rowspan="1" colspan="1">Yes, Mean (SE)</th><th align="left" valign="top" rowspan="1" colspan="1">No, Mean (SE)</th><th align="left" valign="top" rowspan="1" colspan="1">Yes, Mean (SE)</th><th align="left" valign="top" rowspan="1" colspan="1">No, Mean (SE)</th><th align="left" valign="top" rowspan="1" colspan="1">Yes, Mean (SE)</th><th align="left" valign="top" rowspan="1" colspan="1">No, Mean (SE)</th><th align="left" valign="top" rowspan="1" colspan="1">Yes, Mean (SE)</th><th align="left" valign="top" rowspan="1" colspan="1">No, Mean (SE)</th><th align="left" valign="top" rowspan="1" colspan="1">Yes, Mean (SE)</th><th align="left" valign="top" rowspan="1" colspan="1">No, Mean (SE)</th><th align="left" valign="top" rowspan="1" colspan="1">Yes, Mean (SE)</th><th align="left" valign="top" rowspan="1" colspan="1">No, Mean (SE)</th></tr></thead><tbody><tr><td colspan="13" align="left" valign="bottom" rowspan="1">
<hr/>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Poor MH</td><td align="left" valign="top" rowspan="1" colspan="1">2.61 (0.09)<sup><xref rid="TFN13" ref-type="table-fn">a</xref></sup></td><td align="left" valign="top" rowspan="1" colspan="1">1.91 (0.06)</td><td align="left" valign="top" rowspan="1" colspan="1">2.55 (0.12)<sup><xref rid="TFN13" ref-type="table-fn">a</xref></sup></td><td align="left" valign="top" rowspan="1" colspan="1">2.01 (0.06)</td><td align="left" valign="top" rowspan="1" colspan="1">2.61 (0.10)<sup><xref rid="TFN13" ref-type="table-fn">a</xref></sup></td><td align="left" valign="top" rowspan="1" colspan="1">1.85 (0.05)</td><td align="left" valign="top" rowspan="1" colspan="1">2.57 (0.09)<sup><xref rid="TFN13" ref-type="table-fn">a</xref></sup></td><td align="left" valign="top" rowspan="1" colspan="1">1.99 (0.06)</td><td align="left" valign="top" rowspan="1" colspan="1">2.66 (0.16)<sup><xref rid="TFN13" ref-type="table-fn">a</xref></sup></td><td align="left" valign="top" rowspan="1" colspan="1">2.03 (0.06)</td><td align="left" valign="top" rowspan="1" colspan="1">2.63 (0.09)<sup><xref rid="TFN13" ref-type="table-fn">a</xref></sup></td><td align="left" valign="top" rowspan="1" colspan="1">1.88 (0.05)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Not Poor MH</td><td align="left" valign="top" rowspan="1" colspan="1">1.65 (0.11)<sup><xref rid="TFN13" ref-type="table-fn">a</xref></sup></td><td align="left" valign="top" rowspan="1" colspan="1">1.05 (0.03)</td><td align="left" valign="top" rowspan="1" colspan="1">1.83 (0.18)<sup><xref rid="TFN13" ref-type="table-fn">a</xref></sup></td><td align="left" valign="top" rowspan="1" colspan="1">1.08 (0.03)</td><td align="left" valign="top" rowspan="1" colspan="1">1.50 (0.10)<sup><xref rid="TFN13" ref-type="table-fn">a</xref></sup></td><td align="left" valign="top" rowspan="1" colspan="1">1.02 (0.03)</td><td align="left" valign="top" rowspan="1" colspan="1">1.76 (0.13)<sup><xref rid="TFN13" ref-type="table-fn">a</xref></sup></td><td align="left" valign="top" rowspan="1" colspan="1">1.07 (0.03)</td><td align="left" valign="top" rowspan="1" colspan="1">1.86 (0.17)<sup><xref rid="TFN13" ref-type="table-fn">a</xref></sup></td><td align="left" valign="top" rowspan="1" colspan="1">1.10 (0.03)</td><td align="left" valign="top" rowspan="1" colspan="1">1.60 (0.16)<sup><xref rid="TFN13" ref-type="table-fn">a</xref></sup></td><td align="left" valign="top" rowspan="1" colspan="1">1.03 (0.03)</td></tr></tbody></table><table-wrap-foot><fn id="TFN12"><p id="P50">ACE = adverse childhood experience; MH = mental health; SE =
standard error.</p></fn><fn id="TFN13"><label>a</label><p id="P51">Significantly different at <italic toggle="yes">p</italic> &#x0003c; .001; mean
ACE counts compared using t-tests.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="T4" orientation="landscape"><label>Table 4</label><caption><p id="P52">Among adolescents who experienced each adverse childhood experience
(ACE), crude and adjusted associations between mental health (MH) status and
substance use, Adolescent Behavior and Experiences Survey, January&#x02014;June
2021</p></caption><table frame="hsides" rules="none"><colgroup span="1"><col align="left" valign="top" span="1"/><col align="left" valign="top" span="1"/><col align="left" valign="top" span="1"/><col align="left" valign="top" span="1"/><col align="left" valign="top" span="1"/><col align="left" valign="top" span="1"/><col align="left" valign="top" span="1"/><col align="left" valign="top" span="1"/><col align="left" valign="top" span="1"/><col align="left" valign="top" span="1"/><col align="left" valign="top" span="1"/><col align="left" valign="top" span="1"/><col align="left" valign="top" span="1"/><col align="left" valign="top" span="1"/><col align="left" valign="top" span="1"/><col align="left" valign="top" span="1"/><col align="left" valign="top" span="1"/><col align="left" valign="top" span="1"/><col align="left" valign="top" span="1"/><col align="left" valign="top" span="1"/><col align="left" valign="top" span="1"/><col align="left" valign="top" span="1"/><col align="left" valign="top" span="1"/><col align="left" valign="top" span="1"/><col align="left" valign="top" span="1"/></colgroup><thead><tr><th align="left" valign="top" rowspan="1" colspan="1"/><th colspan="4" align="left" valign="top" rowspan="1">Current alcohol use<hr/></th><th colspan="4" align="left" valign="top" rowspan="1">Current binge drinking<hr/></th><th colspan="4" align="left" valign="top" rowspan="1">Alcohol use increased during
COVID-19<hr/></th><th colspan="4" align="left" valign="top" rowspan="1">Current marijuana use<hr/></th><th colspan="4" align="left" valign="top" rowspan="1">Current prescription pain
medication misuse<hr/></th><th colspan="4" align="left" valign="top" rowspan="1">Drug use increased during
COVID-19<hr/></th></tr><tr><th align="left" valign="top" rowspan="1" colspan="1"/><th align="left" valign="top" rowspan="1" colspan="1">% Yes, 95% CI</th><th align="left" valign="top" rowspan="1" colspan="1">%No, 95% CI</th><th align="left" valign="top" rowspan="1" colspan="1">cPR</th><th align="left" valign="top" rowspan="1" colspan="1">aPR<sup><xref rid="TFN17" ref-type="table-fn">a</xref></sup></th><th align="left" valign="top" rowspan="1" colspan="1">% Yes, 95% CI</th><th align="left" valign="top" rowspan="1" colspan="1">%No, 95% CI</th><th align="left" valign="top" rowspan="1" colspan="1">cPR</th><th align="left" valign="top" rowspan="1" colspan="1">aPR<sup><xref rid="TFN17" ref-type="table-fn">a</xref></sup></th><th align="left" valign="top" rowspan="1" colspan="1">% Yes, 95% CI</th><th align="left" valign="top" rowspan="1" colspan="1">%No, 95% CI</th><th align="left" valign="top" rowspan="1" colspan="1">cPR</th><th align="left" valign="top" rowspan="1" colspan="1">aPR<sup><xref rid="TFN17" ref-type="table-fn">a</xref></sup></th><th align="left" valign="top" rowspan="1" colspan="1">% Yes, 95% CI</th><th align="left" valign="top" rowspan="1" colspan="1">%No, 95% CI</th><th align="left" valign="top" rowspan="1" colspan="1">cPR</th><th align="left" valign="top" rowspan="1" colspan="1">aPR<sup><xref rid="TFN17" ref-type="table-fn">a</xref></sup></th><th align="left" valign="top" rowspan="1" colspan="1">% Yes, 95% CI</th><th align="left" valign="top" rowspan="1" colspan="1">%No, 95% CI</th><th align="left" valign="top" rowspan="1" colspan="1">cPR</th><th align="left" valign="top" rowspan="1" colspan="1">aPR<sup><xref rid="TFN17" ref-type="table-fn">a</xref></sup></th><th align="left" valign="top" rowspan="1" colspan="1">% Yes, 95% CI</th><th align="left" valign="top" rowspan="1" colspan="1">%No, 95% CI</th><th align="left" valign="top" rowspan="1" colspan="1">cPR</th><th align="left" valign="top" rowspan="1" colspan="1">aPR<sup><xref rid="TFN17" ref-type="table-fn">a</xref></sup></th></tr></thead><tbody><tr><td colspan="25" align="left" valign="bottom" rowspan="1">
<hr/>
</td></tr><tr><td colspan="25" align="left" valign="top" rowspan="1">Physical abuse during
COVID-19</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Poor MH (n = 253)</td><td align="left" valign="top" rowspan="1" colspan="1">30.4% (22.2&#x02013;38.6)</td><td align="left" valign="top" rowspan="1" colspan="1">69.6% (61.4&#x02013;77.8)</td><td align="left" valign="top" rowspan="1" colspan="1">2.03 (1.32&#x02013;3.13</td><td align="left" valign="top" rowspan="1" colspan="1">1.63 (1.03&#x02013;2.60)</td><td align="left" valign="top" rowspan="1" colspan="1">15.5% (8.9&#x02013;22.2)</td><td align="left" valign="top" rowspan="1" colspan="1">84.5% (77.8&#x02013;91.1)</td><td align="left" valign="top" rowspan="1" colspan="1">1.87 (1.07&#x02013;3.26)</td><td align="left" valign="top" rowspan="1" colspan="1">1.32 (0.68&#x02013;2.53)</td><td align="left" valign="top" rowspan="1" colspan="1">25.3% (17.8&#x02013;32.8)</td><td align="left" valign="top" rowspan="1" colspan="1">74.7% (67.2&#x02013;82.2)</td><td align="left" valign="top" rowspan="1" colspan="1">1.53 (0.92&#x02013;2.54)</td><td align="left" valign="top" rowspan="1" colspan="1">1.37 (0.79&#x02013;2.37)</td><td align="left" valign="top" rowspan="1" colspan="1">22.4% (15.6&#x02013;29.1)</td><td align="left" valign="top" rowspan="1" colspan="1">77.6% (70.9&#x02013;84.4)</td><td align="left" valign="top" rowspan="1" colspan="1">2.00 (1.21&#x02013;3.32)</td><td align="left" valign="top" rowspan="1" colspan="1">1.58 (0.88&#x02013;2.82)</td><td align="left" valign="top" rowspan="1" colspan="1">11.8% (7.9&#x02013;15.6)</td><td align="left" valign="top" rowspan="1" colspan="1">88.2% (84.4&#x02013;92.1)</td><td align="left" valign="top" rowspan="1" colspan="1">1.90 (1.00&#x02013;3.58)</td><td align="left" valign="top" rowspan="1" colspan="1">1.65 (0.90&#x02013;3.02)</td><td align="left" valign="top" rowspan="1" colspan="1">21.9% (15.0&#x02013;28.9)</td><td align="left" valign="top" rowspan="1" colspan="1">78.1% (71.1&#x02013;85.0)</td><td align="left" valign="top" rowspan="1" colspan="1">2.47 (1.34&#x02013;4.40)</td><td align="left" valign="top" rowspan="1" colspan="1">2.19 (1.14&#x02013;4.22)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Not Poor MH (n = 228)</td><td align="left" valign="top" rowspan="1" colspan="1">14.9% (10.0&#x02013;19.9)</td><td align="left" valign="top" rowspan="1" colspan="1">85.1% (80.1&#x02013;90.0)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">8.3% (4.7&#x02013;11.9)</td><td align="left" valign="top" rowspan="1" colspan="1">91.7% (88.1&#x02013;95.3)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">16.5% (9.2&#x02013;23.8)</td><td align="left" valign="top" rowspan="1" colspan="1">83.5% (76.2&#x02013;90.8)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">11.2% (7.0&#x02013;15.4)</td><td align="left" valign="top" rowspan="1" colspan="1">88.8% (84.6&#x02013;93.0)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">6.2% (2.8&#x02013;9.6)</td><td align="left" valign="top" rowspan="1" colspan="1">93.8% (90.4&#x02013;97.2)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">8.9% (4.6&#x02013;13.2)</td><td align="left" valign="top" rowspan="1" colspan="1">91.1% (86.8&#x02013;95.4)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td colspan="25" align="left" valign="top" rowspan="1">Emotional abuse during
COVID-19</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Poor MH (n = 1,018)</td><td align="left" valign="top" rowspan="1" colspan="1">27.9% (23.7&#x02013;32.1)</td><td align="left" valign="top" rowspan="1" colspan="1">72.1% (67.9&#x02013;76.3)</td><td align="left" valign="top" rowspan="1" colspan="1">1.59 (1.32&#x02013;1.91)</td><td align="left" valign="top" rowspan="1" colspan="1">1.41 (1.20&#x02013;1.67)</td><td align="left" valign="top" rowspan="1" colspan="1">14.9% (10.1&#x02013;19.7)</td><td align="left" valign="top" rowspan="1" colspan="1">85.1% (80.3&#x02013;89.9)</td><td align="left" valign="top" rowspan="1" colspan="1">2.01 (1.46&#x02013;2.78)</td><td align="left" valign="top" rowspan="1" colspan="1">1.81 (1.35&#x02013;2.44)</td><td align="left" valign="top" rowspan="1" colspan="1">21.4% (18.9&#x02013;23.9)</td><td align="left" valign="top" rowspan="1" colspan="1">78.6% (76.1&#x02013;81.1)</td><td align="left" valign="top" rowspan="1" colspan="1">1.92 (1.50&#x02013;2.44)</td><td align="left" valign="top" rowspan="1" colspan="1">1.90 (1.50&#x02013;2.39)</td><td align="left" valign="top" rowspan="1" colspan="1">18.2% (13.7&#x02013;22.7)</td><td align="left" valign="top" rowspan="1" colspan="1">81.8% (77.3&#x02013;86.3)</td><td align="left" valign="top" rowspan="1" colspan="1">1.72 (1.23&#x02013;2.41)</td><td align="left" valign="top" rowspan="1" colspan="1">1.62 (1.16&#x02013;2.26)</td><td align="left" valign="top" rowspan="1" colspan="1">8.5% (6.2&#x02013;10.9)</td><td align="left" valign="top" rowspan="1" colspan="1">91.5% (89.1&#x02013;93.8)</td><td align="left" valign="top" rowspan="1" colspan="1">2.26 (1.61&#x02013;3.19)</td><td align="left" valign="top" rowspan="1" colspan="1">2.03 (1.46&#x02013;2.82)</td><td align="left" valign="top" rowspan="1" colspan="1">18.5% (15.6&#x02013;21.4)</td><td align="left" valign="top" rowspan="1" colspan="1">81.5% (78.6&#x02013;84.4)</td><td align="left" valign="top" rowspan="1" colspan="1">2.18 (1.70&#x02013;2.80)</td><td align="left" valign="top" rowspan="1" colspan="1">2.03 (1.54&#x02013;2.67)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Not Poor MH (n = 1,406)</td><td align="left" valign="top" rowspan="1" colspan="1">17.6% (14.9&#x02013;20.2)</td><td align="left" valign="top" rowspan="1" colspan="1">82.4% (79.8&#x02013;85.1)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">7.4% (5.4&#x02013;9.3)</td><td align="left" valign="top" rowspan="1" colspan="1">92.6% (90.7&#x02013;94.6)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">11.2% (8.8&#x02013;13.5)</td><td align="left" valign="top" rowspan="1" colspan="1">88.8% (86.5&#x02013;91.2)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">10.6% (7.9&#x02013;13.2)</td><td align="left" valign="top" rowspan="1" colspan="1">89.4% (86.8&#x02013;92.1)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">3.8% (2.6&#x02013;5.0)</td><td align="left" valign="top" rowspan="1" colspan="1">96.2% (95.0&#x02013;97.4)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">8.5% (6.4&#x02013;10.6)</td><td align="left" valign="top" rowspan="1" colspan="1">91.5% (89.4&#x02013;93.6)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td colspan="25" align="left" valign="top" rowspan="1">Any sexual violence in the past
12 months</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Poor MH (n = 267)</td><td align="left" valign="top" rowspan="1" colspan="1">51.7% (44.0&#x02013;59.5)</td><td align="left" valign="top" rowspan="1" colspan="1">48.3% (40.5&#x02013;56.0)</td><td align="left" valign="top" rowspan="1" colspan="1">1.53 (1.14&#x02013;2.06)</td><td align="left" valign="top" rowspan="1" colspan="1">1.47 (1.05&#x02013;2.05)</td><td align="left" valign="top" rowspan="1" colspan="1">30.7% (22.1&#x02013;39.2)</td><td align="left" valign="top" rowspan="1" colspan="1">69.3% (60.8&#x02013;77.9)</td><td align="left" valign="top" rowspan="1" colspan="1">1.51 (1.00&#x02013;2.29)</td><td align="left" valign="top" rowspan="1" colspan="1">1.73 (1.14&#x02013;2.64)</td><td align="left" valign="top" rowspan="1" colspan="1">32.8% (25.8&#x02013;39.8)</td><td align="left" valign="top" rowspan="1" colspan="1">67.2% (60.2&#x02013;74.2)</td><td align="left" valign="top" rowspan="1" colspan="1">1.62 (0.98&#x02013;2.70)</td><td align="left" valign="top" rowspan="1" colspan="1">1.62 (0.92&#x02013;2.90)</td><td align="left" valign="top" rowspan="1" colspan="1">34.1% (26.3&#x02013;41.9)</td><td align="left" valign="top" rowspan="1" colspan="1">65.9% (58.1&#x02013;73.7)</td><td align="left" valign="top" rowspan="1" colspan="1">1.36 (0.91&#x02013;2.04)</td><td align="left" valign="top" rowspan="1" colspan="1">1.59 (1.00&#x02013;2.52)</td><td align="left" valign="top" rowspan="1" colspan="1">12.2% (8.1&#x02013;16.2)</td><td align="left" valign="top" rowspan="1" colspan="1">87.9% (83.8&#x02013;91.9)</td><td align="left" valign="top" rowspan="1" colspan="1">2.06 (1.01&#x02013;4.21)</td><td align="left" valign="top" rowspan="1" colspan="1">2.39 (1.25&#x02013;4.56)</td><td align="left" valign="top" rowspan="1" colspan="1">31.1% (24.7&#x02013;37.5)</td><td align="left" valign="top" rowspan="1" colspan="1">68.9% (62.5&#x02013;75.3)</td><td align="left" valign="top" rowspan="1" colspan="1">1.13 (0.67&#x02013;1.92)</td><td align="left" valign="top" rowspan="1" colspan="1">1.09 (0.64&#x02013;1.86)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Not Poor MH (n = 157)</td><td align="left" valign="top" rowspan="1" colspan="1">33.7% (25.5&#x02013;41.9)</td><td align="left" valign="top" rowspan="1" colspan="1">66.3% (58.1&#x02013;74.5)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">20.3% (12.5&#x02013;28.0)</td><td align="left" valign="top" rowspan="1" colspan="1">79.7% (72.0&#x02013;87.5)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">20.2% (10.7&#x02013;29.7)</td><td align="left" valign="top" rowspan="1" colspan="1">79.8% (70.3&#x02013;89.3)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">25.0% (15.0&#x02013;35.0)</td><td align="left" valign="top" rowspan="1" colspan="1">75.0% (65.0&#x02013;85.0)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">5.9% (1.9&#x02013;9.9)</td><td align="left" valign="top" rowspan="1" colspan="1">94.1% (90.1&#x02013;98.1)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">27.5% (14.5&#x02013;40.6)</td><td align="left" valign="top" rowspan="1" colspan="1">72.5% (59.4&#x02013;85.5)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td colspan="25" align="left" valign="top" rowspan="1">Physical dating violence in the
past 12 months</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Poor MH (n = 74)</td><td align="left" valign="top" rowspan="1" colspan="1">53.0% (38.2&#x02013;67.8)</td><td align="left" valign="top" rowspan="1" colspan="1">47.0% (32.2&#x02013;61.8)</td><td align="left" valign="top" rowspan="1" colspan="1">1.35 (0.81&#x02013;2.25)</td><td align="left" valign="top" rowspan="1" colspan="1">1.33 (0.80&#x02013;2.23)</td><td align="left" valign="top" rowspan="1" colspan="1">32.7% (18.8&#x02013;46.6)</td><td align="left" valign="top" rowspan="1" colspan="1">67.3% (53.4&#x02013;81.2)</td><td align="left" valign="top" rowspan="1" colspan="1">1.31 (0.58&#x02013;2.99)</td><td align="left" valign="top" rowspan="1" colspan="1">1.53 (0.63&#x02013;3.70)</td><td align="left" valign="top" rowspan="1" colspan="1">38.5% (23.9&#x02013;53.1)</td><td align="left" valign="top" rowspan="1" colspan="1">61.5% (46.9&#x02013;76.1)</td><td align="left" valign="top" rowspan="1" colspan="1">1.27 (0.66&#x02013;2.46)</td><td align="left" valign="top" rowspan="1" colspan="1">1.24 (0.58&#x02013;2.69)</td><td align="left" valign="top" rowspan="1" colspan="1">27.6% (14.5&#x02013;40.7)</td><td align="left" valign="top" rowspan="1" colspan="1">72.4% (59.3&#x02013;85.5)</td><td align="left" valign="top" rowspan="1" colspan="1">0.68 (0.35&#x02013;1.32)</td><td align="left" valign="top" rowspan="1" colspan="1">0.60 (0.28&#x02013;1.30)</td><td align="left" valign="top" rowspan="1" colspan="1">20.5% (8.6&#x02013;32.4)</td><td align="left" valign="top" rowspan="1" colspan="1">79.5% (67.6&#x02013;91.4)</td><td align="left" valign="top" rowspan="1" colspan="1">2.90 (0.79&#x02013;10.63)</td><td align="left" valign="top" rowspan="1" colspan="1">-</td><td align="left" valign="top" rowspan="1" colspan="1">29.4% (17.4&#x02013;41.4)</td><td align="left" valign="top" rowspan="1" colspan="1">70.6% (58.6&#x02013;82.6)</td><td align="left" valign="top" rowspan="1" colspan="1">0.97 (0.43&#x02013;2.20)</td><td align="left" valign="top" rowspan="1" colspan="1">0.81 (0.36&#x02013;1.84)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Not Poor MH (n = 54)</td><td align="left" valign="top" rowspan="1" colspan="1">39.3% (20.8&#x02013;57.9)</td><td align="left" valign="top" rowspan="1" colspan="1">60.7% (9.8&#x02013;13.5)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">24.9% (8.3&#x02013;41.5)</td><td align="left" valign="top" rowspan="1" colspan="1">75.1% (58.5&#x02013;91.7)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">30.3% (11.0&#x02013;49.6)</td><td align="left" valign="top" rowspan="1" colspan="1">69.7% (50.4&#x02013;89.0)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">40.5% (24.0&#x02013;57.0)</td><td align="left" valign="top" rowspan="1" colspan="1">59.5% (43.0&#x02013;76.0)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">7.1% (0.0&#x02013;15.5)</td><td align="left" valign="top" rowspan="1" colspan="1">92.9% (84.5&#x02013;100)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">30.2% (9.3&#x02013;51.1)</td><td align="left" valign="top" rowspan="1" colspan="1">69.8% (48.9&#x02013;90.7)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td colspan="25" align="left" valign="top" rowspan="1">Cyberbullying in the past 12
months</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Poor MH (n = 318)</td><td align="left" valign="top" rowspan="1" colspan="1">33.4% (27.3&#x02013;39.5)</td><td align="left" valign="top" rowspan="1" colspan="1">66.6% (60.5&#x02013;72.7)</td><td align="left" valign="top" rowspan="1" colspan="1">1.75 (1.23&#x02013;2.49)</td><td align="left" valign="top" rowspan="1" colspan="1">1.54 (1.08&#x02013;2.19)</td><td align="left" valign="top" rowspan="1" colspan="1">20.7% (13.5&#x02013;27.9)</td><td align="left" valign="top" rowspan="1" colspan="1">79.3% (72.1&#x02013;86.5)</td><td align="left" valign="top" rowspan="1" colspan="1">2.40 (1.41&#x02013;4.08)</td><td align="left" valign="top" rowspan="1" colspan="1">2.18 (1.30&#x02013;3.64)</td><td align="left" valign="top" rowspan="1" colspan="1">24.3% (18.7&#x02013;29.8)</td><td align="left" valign="top" rowspan="1" colspan="1">75.7% (70.2&#x02013;81.3)</td><td align="left" valign="top" rowspan="1" colspan="1">3.14 (1.73&#x02013;5.71)</td><td align="left" valign="top" rowspan="1" colspan="1">2.62 (1.41&#x02013;4.88)</td><td align="left" valign="top" rowspan="1" colspan="1">18.8% (13.3&#x02013;24.2)</td><td align="left" valign="top" rowspan="1" colspan="1">81.2% (75.8&#x02013;86.7)</td><td align="left" valign="top" rowspan="1" colspan="1">1.59 (0.94&#x02013;2.67)</td><td align="left" valign="top" rowspan="1" colspan="1">1.21 (0.71&#x02013;2.07)</td><td align="left" valign="top" rowspan="1" colspan="1">9.3% (3.7&#x02013;14.8)</td><td align="left" valign="top" rowspan="1" colspan="1">90.7% (85.2&#x02013;96.3)</td><td align="left" valign="top" rowspan="1" colspan="1">3.40 (1.27&#x02013;9.15)</td><td align="left" valign="top" rowspan="1" colspan="1">_</td><td align="left" valign="top" rowspan="1" colspan="1">20.4% (15.7&#x02013;25.0)</td><td align="left" valign="top" rowspan="1" colspan="1">79.6% (75.0&#x02013;84.3)</td><td align="left" valign="top" rowspan="1" colspan="1">1.89 (1.15&#x02013;3.12)</td><td align="left" valign="top" rowspan="1" colspan="1">1.59 (0.95&#x02013;2.65)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Not Poor MH (n = 251)</td><td align="left" valign="top" rowspan="1" colspan="1">19.1% (12.7&#x02013;25.4)</td><td align="left" valign="top" rowspan="1" colspan="1">80.9% (74.6&#x02013;87.3)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">8.6% (4.7&#x02013;12.5)</td><td align="left" valign="top" rowspan="1" colspan="1">91.4% (87.5&#x02013;95.3)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">7.7% (3.6&#x02013;11.9)</td><td align="left" valign="top" rowspan="1" colspan="1">92.3% (88.1&#x02013;96.4)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">11.8% (5.3&#x02013;18.4)</td><td align="left" valign="top" rowspan="1" colspan="1">88.2% (81.6&#x02013;94.7)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">2.7% (0.3&#x02013;5.2)</td><td align="left" valign="top" rowspan="1" colspan="1">97.3% (94.8&#x02013;99.7)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">10.8% (4.6&#x02013;16.9)</td><td align="left" valign="top" rowspan="1" colspan="1">89.2% (83.1&#x02013;95.4)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td colspan="25" align="left" valign="top" rowspan="1">Parent lost job during
COVID-19</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Poor MH (n = 441)</td><td align="left" valign="top" rowspan="1" colspan="1">27.0% (20.5&#x02013;33.4)</td><td align="left" valign="top" rowspan="1" colspan="1">73.0% (66.6&#x02013;79.5)</td><td align="left" valign="top" rowspan="1" colspan="1">1.67 (1.15&#x02013;2.42)</td><td align="left" valign="top" rowspan="1" colspan="1">1.53 (1.09&#x02013;2.13)</td><td align="left" valign="top" rowspan="1" colspan="1">15.5% (10.0&#x02013;21.0)</td><td align="left" valign="top" rowspan="1" colspan="1">84.5% (79.0&#x02013;90.0)</td><td align="left" valign="top" rowspan="1" colspan="1">2.30 (1.36&#x02013;3.89)</td><td align="left" valign="top" rowspan="1" colspan="1">2.07 (1.21&#x02013;3.54)</td><td align="left" valign="top" rowspan="1" colspan="1">19.6% (15.5&#x02013;23.8)</td><td align="left" valign="top" rowspan="1" colspan="1">80.4% (76.2&#x02013;84.5)</td><td align="left" valign="top" rowspan="1" colspan="1">2.28 (1.65&#x02013;3.15)</td><td align="left" valign="top" rowspan="1" colspan="1">2.39 (1.73&#x02013;3.30)</td><td align="left" valign="top" rowspan="1" colspan="1">17.9% (12.1&#x02013;23.7)</td><td align="left" valign="top" rowspan="1" colspan="1">82.1% (76.3&#x02013;87.9)</td><td align="left" valign="top" rowspan="1" colspan="1">1.94 (1.29&#x02013;2.90)</td><td align="left" valign="top" rowspan="1" colspan="1">1.89 (1.32&#x02013;2.71)</td><td align="left" valign="top" rowspan="1" colspan="1">7.3% (4.2&#x02013;10.5)</td><td align="left" valign="top" rowspan="1" colspan="1">92.7% (89.5&#x02013;95.8)</td><td align="left" valign="top" rowspan="1" colspan="1">2.22 (1.22&#x02013;4.06)</td><td align="left" valign="top" rowspan="1" colspan="1">1.86 (1.06&#x02013;3.30)</td><td align="left" valign="top" rowspan="1" colspan="1">17.3% (12.0&#x02013;22.6)</td><td align="left" valign="top" rowspan="1" colspan="1">82.7% (77.4&#x02013;88.0)</td><td align="left" valign="top" rowspan="1" colspan="1">3.73 (2.17&#x02013;6.40)</td><td align="left" valign="top" rowspan="1" colspan="1">3.52 (1.97&#x02013;6.31)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Not Poor MH (n = 754)</td><td align="left" valign="top" rowspan="1" colspan="1">16.2% (11.7&#x02013;20.7)</td><td align="left" valign="top" rowspan="1" colspan="1">83.8% (79.3&#x02013;88.3)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">6.7% (3.9&#x02013;9.5)</td><td align="left" valign="top" rowspan="1" colspan="1">93.3% (90.5&#x02013;96.1)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">8.6% (6.3&#x02013;10.9)</td><td align="left" valign="top" rowspan="1" colspan="1">90.4% (89.1&#x02013;93.7)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">9.3% (6.9&#x02013;11.6)</td><td align="left" valign="top" rowspan="1" colspan="1">90.7% (88.4&#x02013;93.1)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">3.3% (1.7&#x02013;4.9)</td><td align="left" valign="top" rowspan="1" colspan="1">96.7% (95.1&#x02013;98.3)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">4.6% (2.8&#x02013;6.5)</td><td align="left" valign="top" rowspan="1" colspan="1">95.4% (93.5&#x02013;97.2)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td colspan="25" align="left" valign="top" rowspan="1">Food insecurity during
COVID-19</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Poor MH (n = 393)</td><td align="left" valign="top" rowspan="1" colspan="1">27.1% (21.1&#x02013;33.2)</td><td align="left" valign="top" rowspan="1" colspan="1">72.9% (66.8&#x02013;78.9)</td><td align="left" valign="top" rowspan="1" colspan="1">1.80 (1.23&#x02013;2.63)</td><td align="left" valign="top" rowspan="1" colspan="1">1.53 (1.07&#x02013;2.19)</td><td align="left" valign="top" rowspan="1" colspan="1">10.6% (6.4&#x02013;14.8)</td><td align="left" valign="top" rowspan="1" colspan="1">89.4% (85.2&#x02013;93.6)</td><td align="left" valign="top" rowspan="1" colspan="1">1.50 (0.85&#x02013;2.64)</td><td align="left" valign="top" rowspan="1" colspan="1">1.26 (0.73&#x02013;2.17)</td><td align="left" valign="top" rowspan="1" colspan="1">22.2% (17.0&#x02013;27.5)</td><td align="left" valign="top" rowspan="1" colspan="1">77.8% (72.5&#x02013;83.0)</td><td align="left" valign="top" rowspan="1" colspan="1">1.92 (1.30&#x02013;2.81)</td><td align="left" valign="top" rowspan="1" colspan="1">1.83 (1.27&#x02013;2.64)</td><td align="left" valign="top" rowspan="1" colspan="1">14.8% (10.7&#x02013;18.9)</td><td align="left" valign="top" rowspan="1" colspan="1">85.2% (81.1&#x02013;89.3)</td><td align="left" valign="top" rowspan="1" colspan="1">1.43 (0.90&#x02013;2.28)</td><td align="left" valign="top" rowspan="1" colspan="1">1.30 (0.79&#x02013;2.12)</td><td align="left" valign="top" rowspan="1" colspan="1">10.2% (5.9&#x02013;14.6)</td><td align="left" valign="top" rowspan="1" colspan="1">89.8% (85.4&#x02013;94.1)</td><td align="left" valign="top" rowspan="1" colspan="1">2.73 (1.51&#x02013;4.94)</td><td align="left" valign="top" rowspan="1" colspan="1">2.06 (1.13&#x02013;3.76)</td><td align="left" valign="top" rowspan="1" colspan="1">16.6% (12.5&#x02013;20.7)</td><td align="left" valign="top" rowspan="1" colspan="1">83.4% (79.3&#x02013;87.5)</td><td align="left" valign="top" rowspan="1" colspan="1">1.84 (1.27&#x02013;2.67)</td><td align="left" valign="top" rowspan="1" colspan="1">1.62 (1.10&#x02013;2.41)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Not Poor MH (n = 549)</td><td align="left" valign="top" rowspan="1" colspan="1">15.1% (9.5&#x02013;20.6)</td><td align="left" valign="top" rowspan="1" colspan="1">84.9% (79.4&#x02013;90.5)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">7.1% (3.7&#x02013;10.5)</td><td align="left" valign="top" rowspan="1" colspan="1">92.9% (89.5&#x02013;96.3)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">11.6% (7.5&#x02013;15.7)</td><td align="left" valign="top" rowspan="1" colspan="1">88.4% (84.4&#x02013;92.5)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">10.3% (5.8&#x02013;14.9)</td><td align="left" valign="top" rowspan="1" colspan="1">89.7% (85.1&#x02013;94.2)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">3.8% (2.1&#x02013;5.5)</td><td align="left" valign="top" rowspan="1" colspan="1">96.2% (94.5&#x02013;97.9)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">9.0% (5.5&#x02013;12.5)</td><td align="left" valign="top" rowspan="1" colspan="1">91.0% (87.5&#x02013;94.5)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn id="TFN14"><p id="P53">Several adjusted models were unable to converge with selected
covariates due to issues with non-coverage. These are marked with
&#x0201c;&#x02014;&#x0201d;.</p></fn><fn id="TFN15"><p id="P54">Poor mental health is measured by &#x0201c;poor current mental
health&#x0201d; for &#x0201c;current alcohol use&#x0201d;, &#x0201c;current
binge drinking&#x0201d;, &#x0201c;current marijuana use&#x0201d;, and
&#x0201c;current prescription opioid misuse&#x0201d;. Each of these measures
uses a past 30-day window for response. Poor mental health for
&#x0201c;alcohol use increased during COVID-19&#x0201d; and &#x0201c;drug use
increased during COVID-19&#x0201d; is measured by poor mental health during
the COVID-19 pandemic. Each of these measures uses a &#x0201c;during the
COVID-19 pandemic&#x0201d; reference frame.</p></fn><fn id="TFN16"><p id="P55">ACEs = adverse childhood experiences; aPR = adjusted prevalence
ratio; CI = confidence interval; cPR = crude prevalence ratio; MH = mental
health (MH).</p></fn><fn id="TFN17"><label>a</label><p id="P56">Adjusted for sex, race/ethnicity, age, sexual identity, and method
of school instruction. To ensure model convergence due to small sample
sizes, the racial and ethnic categories were recoded to minimize small
sample sizes for some groups. The racial and ethnic variable coding for
these analyses adjusted specifically for differences for non-Hispanic Black,
Hispanic, non-Hispanic Multiracial, non-Hispanic White, and another
race/ethnicity.</p></fn></table-wrap-foot></table-wrap><boxed-text id="BX1" position="float"><caption><title>IMPLICATIONS AND CONTRIBUTION</title></caption><p id="P57">This study enhances the understanding of how poor mental health (MH)
exacerbates the relationships between recent ACEs and substance use during the
pandemic. Substance use was higher among adolescents with ACEs during the pandemic
compared to adolescents without these ACEs. Adolescents experiencing ACEs and poor
MH during the pandemic had higher prevalence of substance use compared to
adolescents experiencing ACEs or poor MH alone.</p></boxed-text></floats-group></article>